<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmacol Res Perspect</journal-id><journal-id journal-id-type="iso-abbrev">Pharmacol Res Perspect</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2052-1707</journal-id><journal-id journal-id-type="publisher-id">PRP2</journal-id><journal-title-group><journal-title>Pharmacology Research &#x00026; Perspectives</journal-title></journal-title-group><issn pub-type="epub">2052-1707</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8023331</article-id><article-id pub-id-type="doi">10.1002/prp2.761</article-id><article-id pub-id-type="publisher-id">PRP2761</article-id><article-categories><subj-group subj-group-type="overline"><subject>Invited Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Invited Reviews</subject></subj-group></article-categories><title-group><article-title>The antimicrobial effect behind <italic>Cannabis sativa</italic>
</article-title><alt-title alt-title-type="left-running-head">SCHOFS et al.</alt-title></title-group><contrib-group><contrib id="prp2761-cr-0001" contrib-type="author" corresp="yes"><name><surname>Schofs</surname><given-names>Laureano</given-names></name><xref ref-type="aff" rid="prp2761-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2761-aff-0002">
<sup>2</sup>
</xref><address><email>lschofs@vet.unicen.edu.ar</email></address></contrib><contrib id="prp2761-cr-0002" contrib-type="author"><name><surname>Sparo</surname><given-names>M&#x000f3;nica D.</given-names></name><xref ref-type="aff" rid="prp2761-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="prp2761-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="prp2761-cr-0003" contrib-type="author"><name><surname>S&#x000e1;nchez Bruni</surname><given-names>Sergio F.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9598-6786</contrib-id><xref ref-type="aff" rid="prp2761-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="prp2761-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="prp2761-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Laboratory of Pharmacology</named-content>
<named-content content-type="organisation-division">Faculty of Veterinary Medicine</named-content>
<institution>Universidad Nacional del Centro de la Provincia de Buenos Aires</institution>
<city>Tandil</city>
<country country="AR">Argentina</country>
</aff><aff id="prp2761-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Tandil Veterinary Research Center (CIVETAN)</named-content>
<institution>Consejo Nacional de Investigaciones Cient&#x000ed;ficas y T&#x000e9;cnicas (CONICET)</institution>
<institution>Comisi&#x000f3;n de investigaciones cient&#x000ed;ficas de la Provincia de Buenos Aires (CICPBA)</institution>
<city>Tandil</city>
<country country="AR">Argentina</country>
</aff><aff id="prp2761-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Clinical Department</named-content>
<named-content content-type="organisation-division">Faculty of Health Sciences</named-content>
<institution>Universidad Nacional del Centro de la Provincia de Buenos Aires</institution>
<city>Tandil</city>
<country country="AR">Argentina</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Laureano Schofs, Laboratory of Pharmacology, Faculty of Veterinary Medicine, Universidad Nacional del Centro de la Provincia de Buenos Aires&#x02010; CIVETAN&#x02010; CONICET, Tandil 7000, Argentina.<break/>
Email: <email>lschofs@vet.unicen.edu.ar</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><volume>9</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/prp2.v9.2</issue-id><elocation-id>e00761</elocation-id><history><date date-type="received"><day>08</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>01</day><month>3</month><year>2021</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright">&#x000a9; 2021 John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics<copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2021 The Authors. <italic>Pharmacology Research &#x00026; Perspectives</italic> published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley &#x00026; Sons Ltd.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:PRP2-9-e00761.pdf"/><abstract id="prp2761-abs-0001"><title>Abstract</title><p>The development of multidrug&#x02010;resistant bacteria has revealed the need for new antimicrobial compounds. <italic>Cannabis sativa</italic> preparations have a long history of medical applications, including the treatment of infectious diseases. This review collects the information about the activity of <italic>C</italic>. <italic>sativa</italic> extracts and its main components (cannabinoids and terpenes) against pathogenic bacteria and fungus, to assess its potential using as antimicrobial agents.</p></abstract><abstract abstract-type="graphical" id="prp2761-abs-0002"><p>
<italic>Cannabis sativa</italic> preparations have a long history of medical applications, including the treatment of infectious diseases. This review collects the information about the activity of <italic>C. sativa</italic> extracts and its main components (cannabinoids and terpenes) against pathogenic bacteria and fungus. All the data presented in this work suggests that cannabinoids and related compounds demonstrated antibacterial activity against clinically important bacteria in the search of new tools as potential antimicrobial agents.<boxed-text position="anchor" content-type="graphic" id="prp2761-blkfxd-0001" orientation="portrait"><graphic xlink:href="PRP2-9-e00761-g004.jpg" position="anchor" id="jats-graphic-1" orientation="portrait"/></boxed-text>
</p></abstract><kwd-group><kwd id="prp2761-kwd-0001">antimicrobial activity</kwd><kwd id="prp2761-kwd-0002">cannabinoids</kwd><kwd id="prp2761-kwd-0003"><italic>Cannabis sativa</italic></kwd><kwd id="prp2761-kwd-0004">terpenes</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="17"/><word-count count="10330"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2021</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.1 mode:remove_FC converted:06.04.2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="prp2761-body-0001"><def-list list-content="abbreviations" id="prp2761-lp-0001"><title>Abbreviations</title><def-item><term>AEA</term><def><p>anandamide</p></def></def-item><def-item><term>AraS</term><def><p>arachidonoyl serine</p></def></def-item><def-item><term>BCE</term><def><p>before the common era</p></def></def-item><def-item><term>CB1 and CB2</term><def><p>cannabinoid receptors type 1 and type 2</p></def></def-item><def-item><term>CBC</term><def><p>cannabichromene</p></def></def-item><def-item><term>CBCA</term><def><p>cannabichromene acid</p></def></def-item><def-item><term>CBD</term><def><p>cannabidiol</p></def></def-item><def-item><term>CBDA</term><def><p>cannabidiol acid</p></def></def-item><def-item><term>CBDV</term><def><p>cannabidivarin</p></def></def-item><def-item><term>CBE</term><def><p>cannabielsoin</p></def></def-item><def-item><term>CBG</term><def><p>cannabigerol</p></def></def-item><def-item><term>CBGA</term><def><p>cannabigerol acid</p></def></def-item><def-item><term>CBL</term><def><p>cannabicyclol</p></def></def-item><def-item><term>CBN</term><def><p>cannabinol</p></def></def-item><def-item><term>CBND</term><def><p>cannabinodiol</p></def></def-item><def-item><term>CBT</term><def><p>cannabitriol</p></def></def-item><def-item><term>EOs</term><def><p>essential oils</p></def></def-item><def-item><term>IL&#x02010;6</term><def><p>interleukin 6</p></def></def-item><def-item><term>LPS</term><def><p>lipopolysaccharide</p></def></def-item><def-item><term>MBC</term><def><p>minimum bactericidal concentration</p></def></def-item><def-item><term>MIC</term><def><p>minimum inhibitory concentration</p></def></def-item><def-item><term>MRSA</term><def><p>Methicillin&#x02010;Resistant <italic>Staphylococcus aureus</italic>
</p></def></def-item><def-item><term>MRSE</term><def><p>Methicillin&#x02010;Resistant <italic>Staphylococcus epidermidis</italic>
</p></def></def-item><def-item><term>MSSA</term><def><p>Methicillin&#x02010;Sensible <italic>Staphylococcus aureus</italic>
</p></def></def-item><def-item><term>OEA</term><def><p>oleoyl ethanolamide</p></def></def-item><def-item><term>THCA</term><def><p>tetrahydrocannabinol acid</p></def></def-item><def-item><term>TLR4</term><def><p>Toll&#x02010;like receptor 4</p></def></def-item><def-item><term>TNF&#x02010;&#x003b1;</term><def><p>tumor necrosis factor &#x003b1;</p></def></def-item><def-item><term>&#x00394;8&#x02010;THC</term><def><p>&#x00394;8&#x02010;tetrahydrocannabinol</p></def></def-item><def-item><term>&#x00394;9&#x02010;THC</term><def><p>&#x00394;9&#x02010;tetrahydrocannabinol</p></def></def-item><def-item><term>&#x00394;9&#x02010;THCV</term><def><p>tetrahydrocannabivarin</p></def></def-item></def-list><sec id="prp2761-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Bacterial resistance to antimicrobial therapy is a major concern all over the world. Infectious disease is the second leading cause of death resulting in 17&#x000a0;million people dying each year from bacterial infections.<xref rid="prp2761-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> The number of resistant organisms to one or more classes of antibiotics is unprecedented. There are more than 15 classes of antibiotics that target different structures of the bacterial cell and none has escaped a resistance mechanism.<xref rid="prp2761-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> The lack of alternatives to mitigate the antimicrobial resistance is based on the low number of new antibiotics developed and approved over the past decades.<xref rid="prp2761-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> In this scenario, alternatives strategies must be explored to mitigate resistant bacterial strains.<xref rid="prp2761-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> Historically, plants have been used as sources of natural products for human health, and many plant extracts and phytochemicals have shown antimicrobial properties against pathogens, including clinical resistant bacterial strains.<xref rid="prp2761-bib-0005" ref-type="ref">
<sup>5</sup>
</xref>, <xref rid="prp2761-bib-0006" ref-type="ref">
<sup>6</sup>
</xref> In some cases, the antibacterial activity of plant extracts was corroborated in animal models of infection.<xref rid="prp2761-bib-0007" ref-type="ref">
<sup>7</sup>
</xref>, <xref rid="prp2761-bib-0008" ref-type="ref">
<sup>8</sup>
</xref> Besides, synergistic effects could be achieved when plant extracts or their bioactive constituentsare combined with antibiotics to antagonize bacterial resistance mechanisms.<xref rid="prp2761-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>
</p><p>
<italic>Cannabis sativa</italic>is a herbaceous annual plant that has been used for centuries for textile, food, medical, recreational, and religious proposes.<xref rid="prp2761-bib-0010" ref-type="ref">
<sup>10</sup>
</xref>
</p><p>The medicinal use of Cannabis has been well documented in many cultures. For example, the first evidence of medical use is attributed to the Chinese Emperor <italic>Shen Nung</italic> (2700 BCE) and the indications for Cannabis use included rheumatic pain, intestinal constipation, menstrual irregularities, and malaria among others.<xref rid="prp2761-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> In an Assyrian culture (1800 BCE) Cannabis was first used medicinally for grief, epilepsy, neuralgia, and pediculosis,<xref rid="prp2761-bib-0012" ref-type="ref">
<sup>12</sup>
</xref> and in Ancient Egypt (1700 BCE) was used as a treatment for the eyes (possibly as an antiinflammatory agent).<xref rid="prp2761-bib-0013" ref-type="ref">
<sup>13</sup>
</xref> In India, the earliest mention of Cannabis is in the <italic>Atharvaveda</italic> (1500 BCE) as a part of the mixture to release from anxiety.<xref rid="prp2761-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>
</p><p>Regarding the potential antimicrobial effects of Cannabis extracts, reports have been found from Egyptian papyruses, African natives, and European and South America folk medicine pointing the use as antiseptic to treat wounds and furuncles and to treat conditions such as erysipelas, anthrax, sepsis, dysentery, and malaria.<xref rid="prp2761-bib-0015" ref-type="ref">
<sup>15</sup>
</xref>
</p><p>In the 19th century, the western medicine adopted the use of Cannabis with the works of Willian B. O&#x02019;Shaughnessy and Jacques&#x02010;Joseph Moreau, describing the utility of Cannabis for rheumatism, convulsions, and muscular spasms of tetanus and rabies, and to treat mental illness respectively.<xref rid="prp2761-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> In 1851, Cannabis extract was listed in the United States Pharmacopeia and several medical articles were published in the United States and Europe.<xref rid="prp2761-bib-0016" ref-type="ref">
<sup>16</sup>
</xref> However, despite the medical benefits of cannabis, its psychoactive effects and its use as a recreational intoxicant, made Cannabis a banned substance for therapeutic use from the British Pharmacopeia in 1932<xref rid="prp2761-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> and the US Pharmacopeia in 1941.<xref rid="prp2761-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>
</p><p>Since the structural elucidation and synthesis of <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=summary%26ligandId=2424">&#x00394;9&#x02010;tetrahydrocannabinol</ext-link> (&#x00394;9&#x02010;THC) and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4150">cannabidiol</ext-link> (CBD) in the 1960s, the discovery of the endocannabinoid system (cannabinoids receptors, endogenous ligands, and enzymatic machinery) in the 1990s and the recognition of the role of the endocannabinoid system in health and disease, the scientific interest for Cannabis has increased significantly.<xref rid="prp2761-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>, <xref rid="prp2761-bib-0017" ref-type="ref">
<sup>17</sup>
</xref> However, the utilization of <italic>Cannabis sativa</italic> and its active compounds against pathogenic bacteria had not taken the attention of the scientific community as compared to other medical applications such as antipsychotic, antiepileptic, anxiolytic, neuroprotective, anti&#x02010;inflammatory, analgesic, antiemetic, antidiabetic, and anticancer.<xref rid="prp2761-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> Nevertheless, recently some new developments related to the antimicrobial effects of cannabinoids have been published, repositioning Cannabis extracts and related compounds as potential antimicrobial agents.</p><p>This article aims to review the effect of Cannabis extracts and its outstanding active compounds (mainly cannabinoids and terpenes) against clinically important bacteria.</p></sec><sec id="prp2761-sec-0002"><label>2</label><title>CANNABIS CHEMICAL COMPOSITION</title><p>
<italic>C</italic>. <italic>sativa</italic> is a dioecious flowering plant with a complex chemical composition.<xref rid="prp2761-bib-0019" ref-type="ref">
<sup>19</sup>
</xref> To the date, it has been reported a total number of 565 natural constituents, 120 of which correspond to the cannabinoid class.<xref rid="prp2761-bib-0020" ref-type="ref">
<sup>20</sup>
</xref> The rest of Cannabis phytochemicals include primary metabolites such as amino acids, fatty acids, and steroids or secondary metabolites as terpenoids, flavonoids, stilbenoids, lignans, and alkaloids among others.<xref rid="prp2761-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>
</p><p>The term cannabinoid includes the compounds isolated from Cannabis plants (also named phytocannabinoids), the pharmacologically analogous synthetic cannabinoids, and the endogenous cannabinoids receptor ligands named endocannabinoids (Figure&#x000a0;<xref rid="prp2761-fig-0001" ref-type="fig">1</xref>).<xref rid="prp2761-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>
</p><fig fig-type="FIGURE" xml:lang="en" id="prp2761-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Schematical structure of the three different types of cannabinoids: endocannabinoids, phytocannabinoids, and synthetic cannabinoids. Adapted from [<xref rid="prp2761-bib-0019" ref-type="ref">19</xref>]</p></caption><graphic id="jats-graphic-3" xlink:href="PRP2-9-e00761-g001"/></fig><p>Cannabinoids are a C<sub>21</sub> terpene phenolic group of compounds, including their analogs and transformation products, predominantly produced by <italic>C</italic>. <italic>sativa</italic>.<xref rid="prp2761-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Cannabinoids have been detected in different parts of the plant, however, they largely accumulate in the secretory cavity of the glandular trichomes of the female flowers.<xref rid="prp2761-bib-0024" ref-type="ref">
<sup>24</sup>
</xref> In fresh Cannabis plants, cannabinoids are biosynthesized in their acid forms (carboxylated form) while during storage and smoking they are non enzymatically decarboxylated into their neutral forms.<xref rid="prp2761-bib-0025" ref-type="ref">
<sup>25</sup>
</xref>
</p><p>Cannabinoids can be divided into 11 major structural types (Figure&#x000a0;<xref rid="prp2761-fig-0002" ref-type="fig">2</xref>): &#x00394;9&#x02010;tetrahydrocannabinol (&#x00394;9&#x02010;THC), &#x00394;8&#x02010;tetrahydrocannabinol (&#x00394;8&#x02010;THC), cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), cannabinodiol (CBND), cannabielsoin (CBE), cannabicyclol (CBL), cannabinol (CBN), cannabitriol (CBT) and miscellaneous types.<xref rid="prp2761-bib-0020" ref-type="ref">
<sup>20</sup>
</xref>
</p><fig fig-type="FIGURE" xml:lang="en" id="prp2761-fig-0002" orientation="portrait" position="float"><label>FIGURE 2</label><caption><p>Major structural types of cannabinoids from <italic>C</italic>. <italic>sativa</italic>. &#x00394;9&#x02010;tetrahydrocannabinol (&#x00394;9&#x02010;THC), &#x00394;8&#x02010;tetrahydrocannabinol (&#x00394;8&#x02010;THC), cannabigerol (CBG), cannabichromene (CBC), cannabidiol (CBD), cannabinodiol (CBND), cannabielsoin (CBE), cannabicyclol (CBL), cannabinol (CBN), cannabitriol (CBT). Adapted from [<xref rid="prp2761-bib-0019" ref-type="ref">19</xref>, <xref rid="prp2761-bib-0023" ref-type="ref">23</xref>]</p></caption><graphic id="jats-graphic-5" xlink:href="PRP2-9-e00761-g002"/></fig><p>&#x00394;9&#x02010;THC, <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=740">cannabinol</ext-link> (CBN), CBD, and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11093">cannabichromene</ext-link> (CBC) are the most abundant phytocannabinoids in <italic>Cannabis</italic>.<xref rid="prp2761-bib-0026" ref-type="ref">
<sup>26</sup>
</xref> The acid form of <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=summary%26ligandId=11094">cannabigerol</ext-link> (CBG), the cannabigerolic acid (CBGA), is the common precursor of <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11091">tetrahydrocannabinolic acid</ext-link> (THCA), <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10600">cannabidiolic acid</ext-link> (CBDA), and cannabichromenic acid (CBCA).<xref rid="prp2761-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> CBG appears as a relatively low concentration intermediate in the cannabis plant and among its suggested properties are anti&#x02010;proliferative, muscle relaxant, antidepressant, and analgesic effects.<xref rid="prp2761-bib-0028" ref-type="ref">
<sup>28</sup>
</xref> &#x00394;9&#x02010;THC is the main psychoactive constituent of <italic>Cannabis sativa</italic> and it was first identified, isolated, and synthesized by Gaoni and Mechoulam in 1964.<xref rid="prp2761-bib-0029" ref-type="ref">
<sup>29</sup>
</xref> According to the phytocannabinoids profile, <italic>Cannabis sativa</italic> is divided into different chemical phenotypes where &#x00394;9&#x02010;THC is the predominant cannabinoid in the drug&#x02010;type plants.<xref rid="prp2761-bib-0030" ref-type="ref">
<sup>30</sup>
</xref> &#x00394;9&#x02010;THC interacts with endogenous cannabinoid receptors types 1 and 2 (<ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=56">CB1</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=57">CB2</ext-link>) and produces psychoactivity, analgesic, muscle relaxant, and antispasmodic effects.<xref rid="prp2761-bib-0031" ref-type="ref">
<sup>31</sup>
</xref> CBN is the product of &#x00394;9&#x02010;THC oxidation, therefore is a minor component of fresh <italic>Cannabis</italic> and exerts a weak CB1 and CB2 partial agonist.<xref rid="prp2761-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> CBC concentrations have been found higher in vegetative stage of cannabis and its appearance is related to the presence of &#x00394;9&#x02010;THC.<xref rid="prp2761-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> CBC showed an antiinflamatory and antinociceptive activity and exerts a CB2 agonism<xref rid="prp2761-bib-0033" ref-type="ref">
<sup>33</sup>
</xref> Meanwhile, CBD is the major non&#x02010;psychotropic constituent of the fiber&#x02010;type varieties of <italic>Cannabis sativa</italic>.<xref rid="prp2761-bib-0034" ref-type="ref">
<sup>34</sup>
</xref> CBD has shown a variety of pharmacological effects and potential therapeutic applications that have taken the attention of many researchers in different areas. Within CBD applications are included inflammatory and neurodegenerative diseases, epilepsy, pain, anxiety, multiple sclerosis, and cancer among others<xref rid="prp2761-bib-0035" ref-type="ref">
<sup>35</sup>
</xref>.</p><p>There are over 200 terpenes and terpenoids in Cannabis.<xref rid="prp2761-bib-0036" ref-type="ref">
<sup>36</sup>
</xref> Terpenes are relatively volatile compounds with an isoprene structure while terpenoids are organic chemicals similar to terpenes but contain oxygen as an additional element in their composition.<xref rid="prp2761-bib-0037" ref-type="ref">
<sup>37</sup>
</xref> Terpenes are divided into five classes namely monoterpenes (C<sub>10</sub>H<sub>16</sub>), sesquiterpenes (C<sub>15</sub>H<sub>24</sub>), diterpenes, triterpenes, and miscellaneous compounds of terpenoid origins.<xref rid="prp2761-bib-0038" ref-type="ref">
<sup>38</sup>
</xref> Terpenes are the primary active components of essential oils (EOs) and exert their pharmacological activity through the interaction with different cell structures (i.e., cell membranes, ion channels, neurotransmitter receptors, second messenger systems, and enzymes).<xref rid="prp2761-bib-0028" ref-type="ref">
<sup>28</sup>
</xref> Myrcene, alpha&#x02010;pinene, beta&#x02010;pinene, limonene, beta&#x02010;caryophyllene, alpha&#x02010;terpinolene, and alpha&#x02010;humulene are among the main components in Cannabis EOs (Figure&#x000a0;<xref rid="prp2761-fig-0003" ref-type="fig">3</xref>).<xref rid="prp2761-bib-0039" ref-type="ref">
<sup>39</sup>
</xref>, <xref rid="prp2761-bib-0040" ref-type="ref">
<sup>40</sup>
</xref>
</p><fig fig-type="FIGURE" xml:lang="en" id="prp2761-fig-0003" orientation="portrait" position="float"><label>FIGURE 3</label><caption><p>Chemical structure of some terpenes found in <italic>Cannabis sativa. Adap</italic>ted from [<xref rid="prp2761-bib-0028" ref-type="ref">28</xref>]</p></caption><graphic id="jats-graphic-7" xlink:href="PRP2-9-e00761-g003"/></fig><p>Monoterpenes, sesquiterpenes, and cannabinoids share a common precursor and most of them also concentrate in the glandular trichomes of Cannabis but generally, the content of terpenes present is smaller than cannabinoids one.<xref rid="prp2761-bib-0041" ref-type="ref">
<sup>41</sup>
</xref> This content varies between different cannabis chemical phenotypes, but it can represent between 12.6% and 31.5% and 0.6%&#x02013;3.3% of cannabis flower dry weight for cannabinoids and terpenes respectively.<xref rid="prp2761-bib-0042" ref-type="ref">
<sup>42</sup>
</xref>
</p><p>Other chemical constituents identified in Cannabis include 50 hydrocarbons, 34 sugars, and related compounds, 27 nitrogenous compounds, 25 non&#x02010;cannabinoids phenols, 23 flavonoids, 18 amino acids, 13 simple ketones, 12 simple aldehydes, 12 simple esters, 11 steroids, 7 simple alcohols, 6 enzymes, 3 proteins, 2 pigments, 1 vitamin and 9 other elements.<xref rid="prp2761-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>
</p><p>As mentioned above, the complex mixture of chemical compounds within <italic>C</italic>. <italic>sativa</italic> makes it difficult to recognize which is the main component behind the antimicrobial effects. Thus, we will briefly describe the antimicrobial reports of different Cannabis extracts and, when is possible, we will focus on the activity of single components related to Cannabis such as cannabinoids and terpenoids.</p></sec><sec id="prp2761-sec-0003"><label>3</label><title>IN VITRO ANTIMICROBIAL EFFECT OF <italic>C. Sativa</italic> DERIVATES</title><p>Whole Cannabis plant and leaves extracts, EOs, seed oils as well as isolated components such as cannabinoids have shown antimicrobial effects against pathogenic bacteria and fungus.<xref rid="prp2761-bib-0043" ref-type="ref">
<sup>43</sup>
</xref> Alkaloids, flavonoids, peptides, tannins, and phenols are also known for their antimicrobial properties<xref rid="prp2761-bib-0037" ref-type="ref">
<sup>37</sup>
</xref> and many of them are found in <italic>C</italic>. <italic>sativa</italic>.<xref rid="prp2761-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Thus, many compounds present in Cannabis extracts could contribute to antimicrobial activity in addition to or synergistic manner.</p><p>The antimicrobial in vitro activity of different <italic>C</italic>. <italic>sativa</italic> derivatives and its related compounds are commented below and are summarized in Table&#x000a0;<xref rid="prp2761-tbl-0001" ref-type="table">1</xref>.</p><table-wrap id="prp2761-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Antimicrobial in vitro activity of <italic>C</italic>. <italic>sativa</italic> derivatives and related compounds</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Plant extract/isolate</th><th align="left" valign="top" rowspan="1" colspan="1">Antimicrobial activity test</th><th align="left" valign="top" rowspan="1" colspan="1">Outstanding antimicrobial activity</th><th align="left" valign="top" rowspan="1" colspan="1">Mild or no antimicrobial activity</th><th align="left" valign="top" rowspan="1" colspan="1">Cite</th></tr></thead><tbody><tr><td align="left" rowspan="10" colspan="1">Cannabis extracts</td><td align="left" rowspan="1" colspan="1">Different parts of <italic>Cannabis sativa</italic> var. <italic>indica</italic> extracts obtained with different solvents</td><td align="left" rowspan="1" colspan="1">Disc diffusion method</td><td align="left" rowspan="1" colspan="1">Antibacterial effect upon Gram&#x02010;positive bacteria: <italic>Staphylococcus aureus, Streptococcus alpha haemolyticus, Streptococcus beta haemolyticus, Enterococcus, Diplococcus pneumoniae, Bacillus subtilis, Bacillus anthracis, Corynebacterium diphtheriae, Corynebacterium cutis,Erysipelothrix rhusiopathiae Clostridium perfringens and Mycobacterium tuberculosis</italic>
</td><td align="left" rowspan="1" colspan="1">Absence of activity against <italic>Escherichia coli, Salmonella typhi, Salmonella paratyphi B, Shigella Shigae, Pseudomona aeruginosa, Proteus vulgaris</italic>, fungi and yeast.</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0015" ref-type="ref">15</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Aqueous, ethanolic and petroleum ether extracts of the leaves of <italic>Cannabis sativa L</italic>. and isolated acidic fraction from ethanolic extract and 2% Sodium Hydroxide extract</td><td align="left" rowspan="1" colspan="1">
<p>Agar diffusion method</p>
<p>Control: cephalexin 0,02&#x000a0;mg/ml and nystatin 0,1&#x000a0;mg/ml</p>
</td><td align="left" rowspan="1" colspan="1">Ethanolic and petroleum ether extracts and the isolated acidic fractions showed marked activity against Gram&#x02010;positive bacteria (<italic>B. subtilis, Bacillus pumilus, S. aureus</italic> and <italic>Micrococcus flavus</italic>), Gram negative bacteria (<italic>P. vulgaris</italic> and <italic>Bordetella bronchiseptica</italic>) and fungi (<italic>Candida albicans</italic> and <italic>Aspergillus niger</italic>) at 1,5 and 10&#x000a0;mg/ml</td><td align="left" rowspan="1" colspan="1">Aqueous extract showed no activity against tested microorganism</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0044" ref-type="ref">44</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Cannabis sativa</italic> L. extracts from leaves and stems</td><td align="left" rowspan="1" colspan="1">
<p>Disc diffusion method.</p>
<p>Control: ticarcillin 75&#x000a0;&#x000b5;g and Chloranphenicol 30&#x000a0;&#x000b5;g</p>
</td><td align="left" rowspan="1" colspan="1">Good antimicrobial activity against <italic>S. aureus</italic> ATCC 12600.</td><td align="left" rowspan="1" colspan="1">No activity against <italic>E. coli</italic> (ATCC 8677), <italic>P. aeruginosa</italic> (ATCC 9721) and <italic>C. albicans</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0045" ref-type="ref">45</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Oil of the seeds, petroleum ether and methanol extracts of the whole plant of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Agar diffusion method.</p>
<p>Control: Ampicillin, Benzyl penicillin, Cloxacillin and Gentamicin (5, 10, 20 and 40&#x000a0;&#x000b5;g/ml), Clotrimazole (5, 10 and 20&#x000a0;&#x000b5;g/ml) and nystatin (12,5, 25 and 50&#x000a0;&#x000b5;g/ml)</p>
<p>MIC (agar plate dilution method)</p>
</td><td align="left" rowspan="1" colspan="1">
<p>The oil of the seeds and the petroleum ether extract exerted pronounced antibacterial activity against <italic>B. subtilis</italic> and <italic>S. aureus</italic>. The oil of seeds exhibited high activity against <italic>P. aeruginosa</italic> and moderate activity against <italic>E. coli</italic> , while the petroleum ether extract exhibited high activity against <italic>E. coli</italic>.</p>
<p>The methanol extract of the whole plant showed also pronounced antibacterial activity against <italic>B. subtilis</italic> and high activity against <italic>E. coli</italic> and <italic>P. aeruginosa</italic>.</p>
<p>MIC of seeds methanol extract: 25&#x000a0;&#x000b5;g/ml for <italic>E. coli and S. aureus</italic>; 50&#x000a0;&#x000b5;g/ml for <italic>P. aeruginosa</italic>.</p>
<p>MIC of whole plant methanol extract: 12,5&#x000a0;&#x000b5;g/ml for <italic>P. aeruginosa</italic>, 25&#x000a0;&#x000b5;g/ml <italic>E. coli</italic> and 50&#x000a0;&#x000b5;g/ml <italic>S. aureus</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>The oil of seed was inactive against <italic>A. niger</italic> and <italic>C. albicans</italic>.</p>
<p>The petroleum ether extract of the whole plant was inactive against <italic>P. aeruginosa</italic> and both fungi.</p>
<p>The methanol extract of the whole plant showed low activity against <italic>S. aureus</italic> and <italic>C. albicans</italic> and inactive against <italic>A. niger</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0046" ref-type="ref">46</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Aquous and acetone extracts of leaves of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Disc diffusion method.</p>
<p>Control: not reported.</p>
</td><td align="left" rowspan="1" colspan="1">Both extracts exherted a inhibition zone (from 3 to 12&#x000a0;mm depending on the concentration and the microorganism) against <italic>P. aeruginosa, Vibro cholerae, Cryptococcus neoformans</italic> and <italic>C. albicans</italic>
</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0047" ref-type="ref">47</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetone, methanol, ethanol and aqueous leaves extracts of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Agar well diffusion method.</p>
<p>Control: Ciprofloxacin and Anphotericin B</p>
<p>MIC determination by modified agar well diffusion method</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Methanolic extract showed marked antibacterial activities against <italic>B. subtilis</italic> and <italic>S. aureus</italic> and moderate against <italic>E. coli</italic>. The rest of the extracts showed moderate antibacterial activity specially agains Gram&#x02010;positive bacteria.</p>
<p>Methanol extract was the most active showing MIC of 1,56&#x000a0;mg/ml against <italic>S. aureus</italic> and <italic>B. subtillis</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>The extracts showed no activity against <italic>P. aeruginosa, Saccharomyces cerevisiae</italic> and <italic>C. albicans</italic>.</p>
<p>
<italic>E. coli</italic> was the least sensitive with MIC of 50&#x000a0;mg/ml</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0048" ref-type="ref">48</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>Cannabis indica</italic> leaves, stems and seeds extracts</td><td align="left" rowspan="1" colspan="1">
<p>Agar well diffusion method</p>
<p>Control: levofloxacin and clotrimazole (5&#x000a0;&#x000b5;g/mcL)</p>
</td><td align="left" rowspan="1" colspan="1">
<p>The methanol extract of leaves was the most active against <italic>S. aureus, B. cereus, Klebsiella pneumoniae</italic> and <italic>Proteus mirabilis</italic>.</p>
<p>
<italic>P. aeruginosa</italic> was generally more sensible to the leaves extracts.</p>
<p>The extracts of plant leaves, seeds and stems showed</p>
<p>antifungal activities against <italic>A. niger, Aspergillus parasiticus</italic>, and <italic>Aspergillus oryzae</italic>
</p>
</td><td align="left" rowspan="1" colspan="1">
<p>
<italic>E. coli, P. mirabilis</italic> and C<italic>. Albicans</italic> showed less sensitivity to the extracts.</p>
<p>All strains showed no inhibition zone to at least one plant extract.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0049" ref-type="ref">49</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Leaf extracts of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Disc diffusion method.</p>
<p>Control: penicillin, methicillin, cefoxitin and vancomycin</p>
</td><td align="left" rowspan="1" colspan="1">Zones of inhibition against clinical and non&#x02010;clinical isolates of Methicillin Resistant <italic>S. aureus</italic> (MRSA). Synergism with other plants.</td><td align="left" rowspan="1" colspan="1">Not reported.</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0050" ref-type="ref">50</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">
<italic>Cannabis sativa L</italic>. seed extracts</td><td align="left" rowspan="1" colspan="1">
<p>MIC well dilution method.</p>
<p>Control: gentamycin and vancomycin</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Selective antimicrobial activity against pathogenic strains (<italic>Enterobacter aerogenes</italic> ATCC, <italic>Salmonella enterica</italic> ser. <italic>Typhimurium</italic> ATCC 14028, <italic>E. coli</italic> ATCC 25922, <italic>S. aureus</italic> ATCC 25923 and <italic>Enterococcus faecalis</italic> ATCC 29212) and no inhibitory effects on the growth of probiotic strains (<italic>Lactobacillus paracasei</italic> MB395, <italic>Lactobacillus reuteri</italic> DSM 20016, <italic>Lactobacillus brevis</italic> ATCC 14869, <italic>Lactobacillus plantarum</italic> MB91, <italic>Bifidobacterium bifidum</italic> B2009, <italic>Bifidobacterium longum</italic> Re11 and <italic>Bifidobacterium breve</italic> B632).</p>
<p>MIC values of 1&#x000a0;mg/ml for <italic>E. coli</italic> ATCC 25922, <italic>S. typhimurium</italic> ATCC 14028, <italic>S. aureus</italic> ATCC 25923 and <italic>E. faecalis</italic> ATCC 29212</p>
</td><td align="left" rowspan="1" colspan="1">
<italic>E. aerogenes</italic> ATCC 13048 MIC 2.5&#x000a0;mg/ml.</td><td align="left" rowspan="2" colspan="1">
<xref rid="prp2761-bib-0051" ref-type="ref">51</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>S. aureus</italic> viability by a double&#x02010;staining fluorescence assay. Biofilm production and inhibition (crystal violet assay)</td><td align="left" rowspan="1" colspan="1">Reduction of cells viability and biofilm formation of <italic>S. aureus</italic>
</td><td align="left" rowspan="1" colspan="1">Concentration lower than 0.5&#x000a0;mg/ml not completely inhibited the biofilm formation.</td></tr><tr><td align="left" rowspan="5" colspan="1">Cannabis EOs</td><td align="left" rowspan="1" colspan="1">EOs of five different cultivars of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">Agar well diffusion method</td><td align="left" rowspan="1" colspan="1">Modest antimicrobial activity against some of the strains mentioned next: <italic>Acinetobacter calcoaceticus, Aeromonas hydrophyla, B. subtilis, Beneckea natriegens, Brevibacterium linens, Brochothrix thermosphacta, E. coli , Flavobacterium suaveolens, Yersinia enterocolitica, Micrococcus luteus</italic> and <italic>S. aureus</italic>
</td><td align="left" rowspan="1" colspan="1">No activity against <italic>Alcaligenes faecalis, Citrobacter freundii, Enterobacter aerogenes, Erwinia carotovora, Klebsiella pneumoniae, Moraxella</italic> spp., <italic>Proteus vulgaris</italic>, <italic>Salmonella pullorum</italic>, <italic>Serratia marcescens</italic> and <italic>Streptococcus faecalis</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0039" ref-type="ref">39</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">EOs from three hemp&#x02010;type varieties of <italic>Cannabis sativa</italic> (Carmagnola, Fibranova and Futura)</td><td align="left" rowspan="1" colspan="1">MIC and MBC by broth dilution method</td><td align="left" rowspan="1" colspan="1">
<p>Activity against <italic>Enterococcus hirae, Enterococcus faecium</italic> and <italic>Streptococcus salivarius</italic> subsp. <italic>thermophilus</italic>. The variety Futura also exhibited good activity against <italic>Clostridium</italic> spp., Gram&#x02010;negative bacteria and partially inhibited yeast growth.</p>
<p>MBC of Futura EO was twice higher its MIC.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Carmagnola and Fibranova EO MIC were above the detection limit for many Clostridia strains.</p>
<p>The essential oils were unable to inhibit <italic>S. cerevisiae</italic>, and <italic>Torulospora delbrueckii</italic> and <italic>Zygosaccharomyces bailii</italic> (except Futura).</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0040" ref-type="ref">40</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">EO from <italic>Cannabis Sativa</italic> variety Futura 75</td><td align="left" rowspan="1" colspan="1">
<p>Kirby&#x02013;Bauer disc diffusion</p>
<p>Method.</p>
<p>Control: erythromycin 15&#x000a0;&#x000b5;g, tetracycline 30&#x000a0;&#x000b5;g, netilimicin 30&#x000a0;&#x000b5;g, levofloxacin 5&#x000a0;&#x000b5;g, cefoxitin 30&#x000a0;&#x000b5;g, linezolid 10&#x000a0;&#x000b5;g, rifampicin 30&#x000a0;&#x000b5;g, and gentamicin 10&#x000a0;&#x000b5;g</p>
<p>MIC and MBC,</p>
<p>Planktonic Susceptibility Assay</p>
<p>Minimum Biofilm Eradication Concentration and Biofilm Eradication Assay and others.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Antimicrobial and antibiofilm effects against five <italic>S. aureus</italic> strains (ATCC 29213 and clinical strains) and antibacterial effect against <italic>Helicobacter pylori</italic>.</p>
<p>For <italic>S. aureus</italic> MIC values of 8&#x000a0;&#x000b5;g/ml and MBC values of 16&#x000a0;&#x000b5;g/ml.</p>
<p>Minimum biofilm eradication concentration (MBEC) between 16 and 24&#x000a0;&#x000b5;g/ml.</p>
<p>For <italic>H. pylori</italic> MIC 32&#x000a0;&#x000b5;g/ml</p>
</td><td align="left" rowspan="1" colspan="1">Against <italic>Candida spp</italic>. and <italic>Malassezia spp</italic>. MIC value above 12,460&#x000a0;&#x000b5;g/ml</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0066" ref-type="ref">66</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">EO from <italic>Cannabis Sativa</italic> variety Futura 75</td><td align="left" rowspan="1" colspan="1">MIC and MBC by microdilution method, motility assay, flagela stain, electron microscopy examination, biofilm formation and others.</td><td align="left" rowspan="1" colspan="1">
<p>Antibacterial activity against <italic>Listeria monocytogenes</italic>.</p>
<p>MBC &#x0003e;2048&#x000a0;&#x003bc;g/ml</p>
<p>Reduced flagelar motility, reduction in biofilm production among others</p>
</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0067" ref-type="ref">67</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Seventeen EOs from different fibre&#x02010;type varieties of <italic>Cannabis sativa</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Agar Well Disk Diffusion Assay.</p>
<p>Control: ampicillin and ciprofloxacin</p>
<p>MIC by microwell dilution method</p>
</td><td align="left" rowspan="1" colspan="1">Good antibacterial activity of six EOs against the Gram&#x02010;positive bacteria (<italic>Staphylococcus</italic> spp., <italic>Enterococcus</italic> spp., L. monocytogenes and <italic>Bacillus</italic> spp.<italic>)</italic>
</td><td align="left" rowspan="1" colspan="1">
<p>Antimicrobial activity and MIC variable between strains and EOs.</p>
<p>The majority of hemp EOs did not exploit any antibacterial activity on <italic>Staphylococcus</italic> bacterial strains. One EO showed no activity against <italic>Listeria</italic> strains</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0053" ref-type="ref">53</xref>
</td></tr><tr><td align="left" rowspan="11" colspan="1">Isolated cannabinoids</td><td align="left" rowspan="1" colspan="1">THC and CBD</td><td align="left" rowspan="1" colspan="1">
<p>MIC by dilution method.</p>
<p>Bacteriostatic and bactericide action against <italic>S. aureus</italic> by determination of number of living cells by standard pour&#x02010;plate method</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Antibacterial activity against <italic>S. aureus</italic> and <italic>Streptococcusspp</italic>. MIC values in the range of 1&#x02013;5&#x000a0;&#x000b5;g/ml.</p>
<p>THC and CBD resulted both bacteriostatic and bactericidal against <italic>S. aureus</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Less activity in presence of horse blood in the agar.</p>
<p>
<italic>E. coli , S. typhi</italic> and <italic>P. vulgaris</italic> MIC &#x0003e;100&#x000a0;&#x000b5;g/ml.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0068" ref-type="ref">68</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBC, homologs and isomers</td><td align="left" rowspan="1" colspan="1">
<p>Agar well diffusion assay</p>
<p>MIC by two&#x02010;fold serial dilution method.</p>
<p>Control: streptomycin and anphotericin B.</p>
</td><td align="left" rowspan="1" colspan="1">Strong antibacterial activity against <italic>B. subtillis, S. aureus</italic> and <italic>Mycobacterium smegmatis</italic> and mild to moderat activity against <italic>Trichophyton mentagrophytes</italic>
</td><td align="left" rowspan="1" colspan="1">Poor to none activity agaist <italic>E. coli, P. aeruginosa, C. albicans, S. cerevisiae</italic> and <italic>A. niger</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0026" ref-type="ref">26</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBC, analogs, homologs and isomers, CBG, homologs and isomers, &#x00394;9&#x02010;THC, &#x00394;8&#x02010;THC, CBD, CBN and CBL</td><td align="left" rowspan="1" colspan="1">
<p>Agar well diffusion assay</p>
<p>MIC by two&#x02010;fold serial dilution method</p>
<p>Control: streptomycin and anphotericin B.</p>
</td><td align="left" rowspan="1" colspan="1">CBC and CBG and theirs isomeres and homologs were the most active compounds against Gram&#x02010;positive bacteria and <italic>T. mentagrophytes</italic>
</td><td align="left" rowspan="1" colspan="1">Mild inhibitory activity against Gram&#x02010;negative bacteria (<italic>E</italic>.<italic>coli</italic> and <italic>P. aeruginosa)</italic> and fungi</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0069" ref-type="ref">69</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD, CBC, CBG, THC and CBN, and related compunds</td><td align="left" rowspan="1" colspan="1">
<p>MIC by plates dilution method.</p>
<p>Control: norfloxacin, erythromycin, tetracycline and oxacillin.</p>
</td><td align="left" rowspan="1" colspan="1">All major cannabinoids showed potent antibacterial activity against MRSA, with MIC values in the 0.5&#x02013;2&#x000a0;<italic>&#x003bc;</italic>g/ml range.</td><td align="left" rowspan="1" colspan="1">Some compounds exhibited MIC values above 128&#x000a0;&#x000b5;g/ml and 256&#x000a0;&#x000b5;g/ml.</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0072" ref-type="ref">72</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">(&#x000b1;)&#x02212;4&#x02010;acetoxycannabichromene; (&#x000b1;)&#x02212;3&#x02033;&#x02010;hydroxy&#x02010;&#x00394;(4&#x02033;,5&#x02033;)&#x02010;cannabichromene; (&#x02212;)&#x02212;7&#x02010;hydroxycannabichromene; (&#x02212;)&#x02212;7R&#x02010;cannabicoumarononic acid A;5&#x02010;acetyl&#x02212;4&#x02010;hydroxycannabigerol; 4&#x02010;acetoxy&#x02212;2&#x02010;geranyl&#x02212;5&#x02010;hydroxy&#x02212;3&#x02010;n&#x02010;pentylphenol; 8&#x02010;hydroxycannabinol; 8&#x02010;hydroxycannabinolic acid A and 2&#x02010;geranyl&#x02212;5&#x02010;hydroxy&#x02212;3&#x02010;n&#x02010;pentyl&#x02212;1,4&#x02010;benzoquinone</td><td align="left" rowspan="1" colspan="1">
<p>IC<sub>50</sub>determination.</p>
<p>Control: ciprofloxacin and anphotericin B.</p>
</td><td align="left" rowspan="1" colspan="1">4&#x02010;acetoxy&#x02010;2&#x02010;geranyl&#x02010;5&#x02010;hydroxy&#x02010;3&#x02010;n&#x02010;pentylphenol showed antibacterial activity againts <italic>S. aureus</italic> and MRSA, 8&#x02010;hydroxycannabinol showed antifungal activity against <italic>C. albicans</italic>) and 5&#x02010;acetyl&#x02010;4&#x02010;hydroxycannabigerol showed antileishmanial activity (<italic>Leishmania donovani)</italic>
</td><td align="left" rowspan="1" colspan="1">The rest of the compounds tested showed weak antimicrobial activity.</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0070" ref-type="ref">70</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD</td><td align="left" rowspan="1" colspan="1">
<p>Transmission electron miscrocopy, Western Blotting, proteomics, Disc diffusion test and others.</p>
<p>Control: colistin (10&#x000a0;&#x003bc;g/ml), rifampicin (15&#x000a0;&#x003bc;g/ml),</p>
<p>erythromycin (50&#x000a0;&#x003bc;g/ml), kanamycin (1,000&#x000a0;&#x003bc;g/ml) and vancomycin (5&#x000a0;&#x003bc;g/ml).</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Inhibition of membrane vesicule release from <italic>E. coli</italic> VCS257</p>
<p>CBD alone at 5&#x000a0;&#x000b5;M disminuyed <italic>E. coli</italic> cell viability</p>
<p>CBD enhanced antibacterial effect of erythromycin and rifampicin against <italic>E. coli</italic> VCS257and increased the antibacterial effect of kanamycin against <italic>S. aureus</italic> subsp. <italic>aureus</italic> Rosenbach.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>Negligible inhibition of membrane vesicule release from <italic>S. aureus</italic>.</p>
<p>CBD had no effect on <italic>S. aureus</italic> cell viability.</p>
<p>CBD did not enhance bactericidal activity in the other combinations tested and</p>
<p>reduced antibacterial effects of erythromycin and</p>
<p>rifampicin against <italic>S. aureus</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0077" ref-type="ref">77</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD, CBC. CBN, CBG and CBGA</td><td align="left" rowspan="1" colspan="1">
<p>Colony count reduction.</p>
<p>Control: comercial oral care products</p>
</td><td align="left" rowspan="1" colspan="1">Reduced the bacterial colony count in dental plaque.</td><td align="left" rowspan="1" colspan="1">Not reported</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0071" ref-type="ref">71</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBC, CBD, CBG, CBN, THC and precursors</td><td align="left" rowspan="1" colspan="1">Susceptibility test, MIC, biofilm formation with static abiotic solid&#x02010;surface assays, studies of mechanism and others.</td><td align="left" rowspan="1" colspan="1">
<p>CBG, CBD, CBN, CBCA and THC MIC 2&#x000a0;&#x000b5;g/ml against MRSA.</p>
<p>CBG MIC<sub>904&#x000a0;</sub>&#x000b5;g/mlfor MRSA isolates</p>
<p>Antibacterial and antibiofilm activity of cannabinoids against MRSA.</p>
<p>CBG targeted the cytoplasmic membrane of Gram&#x02010;positive bacteria and Gram&#x02010;negative bacteria (whose outer membranewas permeabilized). The combination of cannabinoids with polymyxin B was effective against multi&#x02010;drug resistant Gram&#x02010;negative pathogens.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>11&#x02010;nor&#x02212;9&#x02010;carboxy&#x02010;&#x00394;9&#x02010;THC, and 11&#x02010;hydroxy&#x02010;&#x00394;9&#x02010;THC and cannabicylol were inactive against MRSA (MIC &#x0003e;32&#x000a0;&#x000b5;g/ml)</p>
<p>MICs &#x0003e;128&#x000a0;&#x003bc;g/ml for <italic>E</italic>.<italic>coli</italic>
</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0073" ref-type="ref">73</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD</td><td align="left" rowspan="1" colspan="1">
<p>MIC determination</p>
<p>Transmission electron microscopy, composition of peptidoglycan in HPLC chromatogram, qPCR and others.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>CBD MIC 4&#x000a0;&#x000b5;g/ml for MRSA, <italic>L. monocytogenes</italic> and MRSE and 8&#x000a0;&#x000b5;g/ml for <italic>E. faecalis</italic>.</p>
<p>CBD potentiated the effect of bacitracinagainst <italic>Staphylococcus</italic> species, <italic>L. monocytogenes</italic> and<italic>E. faecalis</italic>. The combination CBD and bacitracin induced septa formations during cell division and membrane irregularities, and reduced the expression of the gene <italic>ezrA</italic>in <italic>S. aureus</italic>.</p>
</td><td align="left" rowspan="1" colspan="1">
<p>MIC &#x0003e;128&#x000a0;&#x000b5;g/ml for <italic>P. aeruginosa,</italic>
</p>
<p>
<italic>Salmonella typhimurium, K. pneumoniae, and E. coli</italic>. No synergims was found between CBD and bacitracin against Gram&#x02010;negative bacteria.</p>
<p>CBD and bacitracin alone caused no morphological changes in <italic>S. aureus</italic>. In addition, CBD or combinated with bacitracin did not cause changes in the cell wall composition.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0078" ref-type="ref">78</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBCA and related synthetic analogues</td><td align="left" rowspan="1" colspan="1">MIC determination, time&#x02010;kill analysis, phase&#x02010;contrast and fluorescence microscopy</td><td align="left" rowspan="1" colspan="1">CBCA MIC 3,9&#x000a0;&#x000b5;M for MRSA, 7,8&#x000a0;&#x000b5;M for MSSA and 7,8&#x000a0;&#x000b5;M for vancomycin&#x02010;resistant <italic>E. faecalis</italic>. Potent and rapid bactericidal activity of CBCA against MRSA with low and high cell density. Bacterial degeneration and cell lysis of <italic>B.. subtilis</italic> due to membrane and nucleoid alteration.</td><td align="left" rowspan="1" colspan="1">
<p>Synthetic CBCA analogues showed no antibacterial activity (with the exception of CBDVM against MRSA)</p>
<p>In time&#x02010;kill analysis, the concentration of viable bacteria increased more than 5&#x02010;log after 24&#x000a0;h treatment with CBCA.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0076" ref-type="ref">76</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">CBD and CBDA</td><td align="left" rowspan="1" colspan="1">MIC determination by broth microdilution method, time&#x02010;kill analysis for <italic>S. aureus</italic> and synergy test with CBD and conventional antibiotics (clindamycin, ofloxacin, meropenem, tobramycin, teicoplanin, methicillin and vancomycin) on <italic>S aureus</italic> using checkboard method.</td><td align="left" rowspan="1" colspan="1">CBD MIC 1&#x000a0;&#x000b5;g/ml for <italic>S. aureus</italic> ATCC 25923 and MRSA (USA 300) and 2&#x000a0;&#x000b5;g/ml for <italic>S. epidermidis</italic> (CA71 and ATCC51625). CBDA MIC 2&#x000a0;&#x000b5;g/ml for <italic>S. aureus</italic> ATCC 25923 and 4&#x000a0;&#x000b5;g/ml for MRSA and <italic>S. epidermidis</italic>. CBD exherted rapid killing effect against <italic>S.aureus</italic> ATCC 25923 and MRSA.</td><td align="left" rowspan="1" colspan="1">Neither CBD or CBDA showed inhibitory activity against <italic>E. coli</italic> ATCC 25922 and <italic>P. aeruginosa</italic> PA01. In synergy test, CBD showed an indifferent effect with the antibiotics tested.</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0075" ref-type="ref">75</xref>
</td></tr><tr><td align="left" rowspan="2" colspan="1">Endocannabinoids and endocannabinoid&#x02010;like compounds</td><td align="left" rowspan="1" colspan="1">Anandamide (AEA) and arachidonoyl serine (AraS)</td><td align="left" rowspan="1" colspan="1">
<p>MIC by standard broth microdilution method.</p>
<p>Control: gentamycin.</p>
<p>Biofilm formation by crystal violet staining, MBC, cell surface hydrophopicity test, cell agragation, membrane potential test and others</p>
</td><td align="left" rowspan="1" colspan="1">Dose dependent antibiofilm activity against MRSA. Alterated biofilm associated properties (hydrophobicity and cell agregation) and modified bacterial membrane potential.</td><td align="left" rowspan="1" colspan="1">
<p>AEA MIC &#x0003e;256&#x000a0;&#x000b5;g/ml</p>
<p>AraS MIC variable between MRSA strains from 32 up to above 256&#x000a0;&#x000b5;g/ml</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0074" ref-type="ref">74</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Anandamide (AEA), palmitoylethanolamide (PEA), oleoylethanolamide (OEA) and stearoylethanolamide (SEA)</td><td align="left" rowspan="1" colspan="1">Effect on planktonic cells and biofilm assay.</td><td align="left" rowspan="1" colspan="1">AEA and OEA exhibited a synergistic antibacterial effect with poly&#x02010;L&#x02010;lysine against <italic>Streptococcus mutans</italic>. AEA showed a partial antibiofilm formation effect in <italic>S. mutans</italic>.</td><td align="left" rowspan="1" colspan="1">
<p>None of the agents showed MIC at all tested doses.</p>
<p>PEA and SEA alone or in combination with poly&#x02010;L&#x02010;lisine had no effect on <italic>S. mutans</italic> growth or in biofilm formation. AEA alone and AEA mixed with poly&#x02010;L&#x02010;lysine at doses up to 12.5&#x000a0;&#x003bc;g/ml had no effect on bacterial growth.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0079" ref-type="ref">79</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Synthetic cannabinoids</td><td align="left" rowspan="1" colspan="1">HU&#x02010;210</td><td align="left" rowspan="1" colspan="1">MIC determination, bioluminescence assay, biofilm formation, biomass determination by crystal violet stain, qPCR, swimming motility assay and others</td><td align="left" rowspan="1" colspan="1">Interference of bacterial signal&#x02010;transduction systems in <italic>Vibrio harveyi</italic> by targeting the the AI&#x02212;2 cascade. Reduction on swimming motility and biofilm formation.</td><td align="left" rowspan="1" colspan="1">
<p>Growth of <italic>V. harveyi</italic> strains was unaffected at all tested concentrations(0.2&#x02013;200&#x000a0;&#x003bc;g/ml) of HU&#x02212;210.</p>
<p>There was no uniform antibiofilm effect on all the strains tested.</p>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="prp2761-bib-0080" ref-type="ref">80</xref>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><sec id="prp2761-sec-0004"><label>3.1</label><title>Cannabis crude extracts</title><p>Early reports on the antimicrobial activity of Cannabis come from Kabel&#x000ed;k et al. in 1960. In this work, extracts from different parts of <italic>C. sativa</italic> var. <italic>indica</italic> were tested for antibacterial activity against Gram&#x02010;positive and Gram&#x02010;negative microorganisms. These extracts showed a bactericidal effect upon Gram&#x02010;positive bacteria and <italic>Mycobacterium tuberculosis</italic> but showed no effect on Gram&#x02010;negative bacteria as well as fungi and yeast assayed.<xref rid="prp2761-bib-0015" ref-type="ref">
<sup>15</sup>
</xref>
</p><p>Crude aqueous, ethanolic, and petroleum ether extracts of the leaves of <italic>C</italic>. <italic>sativa</italic> along with isolated acidic fractions were studied for antimicrobial activity. Ethanolic and petroleum ether extracts, as well as the isolated acidic fraction, showed marked activity against Gram&#x02010;positive and Gram&#x02010;negative bacteria, and fungi (<italic>Candida albicans</italic> and <italic>Aspergillus niger</italic>), while the aqueous extract did not show any activity.<xref rid="prp2761-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>
</p><p>Leaves and stems extracts of <italic>C</italic>. <italic>sativa</italic> showed a wide inhibition zone diameter against <italic>Staphylococcus aureus</italic> assessed by a disc diffusion method.<xref rid="prp2761-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>
</p><p>Seed oil and organic solvent extract of the whole <italic>C</italic>. <italic>sativa</italic> plants were tested against <italic>Bacillus subtilis, S. aureus, Escherichia coli, Pseudomonas aeruginosa, A. niger, and C. albicans</italic>. Generally, as seen in previous reports a pronounced activity was found against Gram&#x02010;positive bacteria and moderate to none activity against Gram&#x02010;negative and fungi.<xref rid="prp2761-bib-0046" ref-type="ref">
<sup>46</sup>
</xref>
</p><p>Antibacterial and antifungal activity of different extracts (aqueous and acetone extracts) of <italic>C</italic>. <italic>sativa</italic> leaves was tested by Lone and Lone (2012). In this work, both extracts showed inhibition zones against <italic>P. aeruginosa, Vibro cholerae, Cryptococcus neoformans</italic>, and <italic>C. albicans</italic> at 5&#x000a0;&#x000b5;g/ml and 10&#x000a0;&#x000b5;g/ml concentration.<xref rid="prp2761-bib-0047" ref-type="ref">
<sup>47</sup>
</xref>
</p><p>Extracts of leaves of <italic>C</italic>. <italic>sativa</italic> and two other plants were obtained with four different solvents and tested for antimicrobial activity against six microbial cultures (two Gram&#x02010;positive, two Gram&#x02010;negative, and two yeast). <italic>C</italic>. <italic>sativa</italic> showed the best antibacterial activity and the methanolic extract of Cannabis was the most active with marked antibacterial activity against <italic>B. subtilis</italic> and <italic>S</italic>. <italic>aureus</italic>.<xref rid="prp2761-bib-0048" ref-type="ref">
<sup>48</sup>
</xref>
</p><p>The antimicrobial activity of <italic>Cannabis</italic> (<italic>indica)</italic> leaves, stems, and seeds extracts was evaluated by Isahq et al. (2015). Six multidrug&#x02010;resistant bacterial strains (<italic>S</italic>. <italic>aureus</italic>, <italic>Bacillus cereus</italic>, <italic>E</italic>. <italic>coli</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>P</italic>. <italic>aeruginosa</italic>, and <italic>Proteus mirabilis</italic>) and five fungal strains (<italic>Aspergillus</italic> and <italic>Candida</italic> genera) were used for susceptibility test. All extracts revealed a range of antimicrobial activity.<xref rid="prp2761-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>
</p><p>The antibacterial activity of dried leaves extracts of <italic>C</italic>. <italic>sativa</italic> and other Indian medicinal plants were determined using a disc diffusion method by Chakraborty et al. (2018). Clinical and non&#x02010;clinical isolates of Methicillin&#x02010;Resistant <italic>S</italic>. <italic>aureus</italic> (MRSA) were tested and the growth of all of them resulted inhibited by crude ethanol extracts of the assayed plants. Moreover, a synergism between Cannabis and the other extracts was found.<xref rid="prp2761-bib-0050" ref-type="ref">
<sup>50</sup>
</xref>
</p><p>The effect of <italic>C</italic>. <italic>sativa</italic> seed extracts on pathogenic (Gram&#x02010;positive and Gram&#x02010;negative strains) and beneficial probiotic bacteria (<italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic>) was evaluated. Hemp seed extract showed an inhibitory effect on pathogens while not marked antimicrobial activity against the tested probiotic strains was seen. Besides, <italic>Cannabis</italic> extracts also reduced cell viability and biofilm formation of <italic>S</italic>. <italic>aureus</italic>.<xref rid="prp2761-bib-0051" ref-type="ref">
<sup>51</sup>
</xref>
</p></sec><sec id="prp2761-sec-0005"><label>3.2</label><title>Cannabis EOs and terpenes</title><p>EOs are aromatic oily liquids obtained from plant material, chemically constituted mainly by a mixture of terpenoids compounds, which are responsible for the biological activity of EOs and particularly for the antimicrobial activity.<xref rid="prp2761-bib-0052" ref-type="ref">
<sup>52</sup>
</xref> Additionally, low concentration of some cannabinoids such as CBD, CBC, and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11092">cannabidivarin</ext-link> (CBDV) can also be present in Cannabis EOs exerting synergistic interactions.<xref rid="prp2761-bib-0053" ref-type="ref">
<sup>53</sup>
</xref>
</p><p>Antimicrobial activity of terpenes compounds such as beta&#x02010;caryophyllene,<xref rid="prp2761-bib-0054" ref-type="ref">
<sup>54</sup>
</xref>, <xref rid="prp2761-bib-0055" ref-type="ref">
<sup>55</sup>
</xref>, <xref rid="prp2761-bib-0056" ref-type="ref">
<sup>56</sup>
</xref>, <xref rid="prp2761-bib-0057" ref-type="ref">
<sup>57</sup>
</xref>, <xref rid="prp2761-bib-0058" ref-type="ref">
<sup>58</sup>
</xref> caryophyllene oxide,<xref rid="prp2761-bib-0059" ref-type="ref">
<sup>59</sup>
</xref>, <xref rid="prp2761-bib-0060" ref-type="ref">
<sup>60</sup>
</xref>, <xref rid="prp2761-bib-0061" ref-type="ref">
<sup>61</sup>
</xref>, myrcene,<xref rid="prp2761-bib-0062" ref-type="ref">
<sup>62</sup>
</xref> limonene,<xref rid="prp2761-bib-0063" ref-type="ref">
<sup>63</sup>
</xref>, <xref rid="prp2761-bib-0064" ref-type="ref">
<sup>64</sup>
</xref> alpha&#x02010;pinene and beta&#x02010;pinene,<xref rid="prp2761-bib-0065" ref-type="ref">
<sup>65</sup>
</xref> has already been reported. Regarding Cannabis, a moderate antimicrobial activity of different EOs from <italic>C</italic>. <italic>sativa</italic> was reported against potential pathogen microorganisms such as <italic>Acinetobacter calcoaceticus, B. subtilis, E. coli, Yersinia enterocolitica, Micrococcus luteus</italic>, and <italic>S. aureus</italic>.<xref rid="prp2761-bib-0039" ref-type="ref">
<sup>39</sup>
</xref>
</p><p>The antimicrobial activity and terpene characterization of EOs extracted from the inflorescence of three different varieties of <italic>C</italic>. <italic>sativa</italic> were also assessed by Nissen et al., 2010. Besides, single terpenes standard antimicrobial activity was determined. All the EOs exhibited good antimicrobial effect, especially against Gram&#x02010;positive pathogens from <italic>Enterococcus</italic> and <italic>Streptococcus</italic> genera. One of the EOs (named Futura) gave satisfactory results against Clostridia, Gram&#x02010;negative pathogens, and some yeasts. Among terpenes standards, alpha&#x02010;pinene was the most effective against Gram&#x02010;positive and Gram&#x02010;negative bacteria.<xref rid="prp2761-bib-0040" ref-type="ref">
<sup>40</sup>
</xref>
</p><p>A similar variety of <italic>C. sativa L</italic>. EO (Futura 75) showed antibacterial activity against clinically relevant (multidrug&#x02010;sensible and multidrug&#x02010;resistant) <italic>S</italic>. <italic>aureus</italic> and <italic>Helicobacter pylori</italic> strains. Besides, the EO demonstrated the capacity to eradicate biofilms developed by <italic>S</italic>. <italic>aureus</italic>.<xref rid="prp2761-bib-0066" ref-type="ref">
<sup>66</sup>
</xref> Finally, <italic>C</italic>. <italic>sativa</italic> var. Futura 75 also showed moderated bactericidal activity against <italic>Listeria monocytogenes</italic>. It also affected <italic>L. monocytogenes</italic> virulence traits, reducing the motility, the invasion ability, and the biofilm formation capacity of the bacteria.<xref rid="prp2761-bib-0067" ref-type="ref">
<sup>67</sup>
</xref>
</p><p>Recently, Iseppi et al. (2019) reported the chemical characterization of 17 EOs from Cannabis and its antibacterial activity. No antimicrobial activity was found against Gram&#x02010;negative bacteria, however, good antibiotic activity was observed against Gram&#x02010;positive microorganism. Some samples showed MIC values against <italic>Enterococcus, Listeria, Bacillus</italic>, and <italic>Staphylococcus</italic> similar toor lower than conventional antibiotics (ampicillin and ciprofloxacin). Among pure compounds, CBD, alpha&#x02010;pinene, beta&#x02010;pinene, and beta&#x02010;myrcene exhibited good antibiotic activity, especially toward <italic>Listeria and Enterococcus</italic> strains.<xref rid="prp2761-bib-0053" ref-type="ref">
<sup>53</sup>
</xref>
</p></sec><sec id="prp2761-sec-0006"><label>3.3</label><title>Cannabinoids</title><p>The first report addressed to quantified the antimicrobial activity of the purified cannabinoids of <italic>C</italic>. <italic>sativa</italic> (&#x00394;9&#x02010;THC and CBD) was carried out by VanKlingeren &#x00026; Ten Ham (1976). They established a bacteriostatic and bactericidal activity in the range of 1&#x02013;5&#x000a0;&#x000b5;g/ml for <italic>S</italic>. <italic>aureus</italic> and <italic>Streptococcus</italic> spp. but found no activity against Gram&#x02010;negative bacteria. They also reported a decreased antibiotic activity in presence of horse serum.<xref rid="prp2761-bib-0068" ref-type="ref">
<sup>68</sup>
</xref>
</p><p>Later on, Turner &#x00026; ElSohly (1981) studied the biological activity of CBC, and related compounds, and found out anti&#x02010;inflammatory and antimicrobial effects of these compounds. They reported a strong antibacterial activity and a mild to the moderate antifungal activity of CBC and its isomers and homologs that, in some cases, showed larger inhibition zones than the positive control standards.<xref rid="prp2761-bib-0026" ref-type="ref">
<sup>26</sup>
</xref> Besides, these researchers tested the antimicrobial activity of different cannabinoids against Gram&#x02010;positive bacteria, Gram&#x02010;negative bacteria, and fungi. Of those compounds, CBC and CBG, and their isomers and homologs were the most active compounds against bacteria and fungi assayed.<xref rid="prp2761-bib-0069" ref-type="ref">
<sup>69</sup>
</xref>
</p><p>More recently, nine new cannabinoids were isolated and three of them namely 4&#x02010;acetoxy&#x02010;2&#x02010;geranyl&#x02010;5&#x02010;hydroxy&#x02010;3&#x02010;n&#x02010;pentylphenol, 8&#x02010;hydroxycannabinol and 5&#x02010;acetyl&#x02010;4&#x02010;hydroxycannabigerol showed antibacterial (<italic>S</italic>. <italic>aureus</italic> and MRSA), antifungal (<italic>C. albicans</italic>), and antileishmanial (<italic>Leishmania donovani)</italic> activity respectively.<xref rid="prp2761-bib-0070" ref-type="ref">
<sup>70</sup>
</xref>
</p><p>Pure cannabinoids (CBD, CBC. CBN, CBG, CBGA) have also proven to be more effective in reducing the colony count of dental plaque&#x02010;associated bacterial strains as compared to commercial oral care products.<xref rid="prp2761-bib-0071" ref-type="ref">
<sup>71</sup>
</xref>
</p><p>Concerning resistant bacteria, Appendino and co&#x02010;workers tested the five major cannabinoids (CBD, CBC, CBG, &#x00394;9&#x02010;THC, and CBN) and related compounds against a variety of multidrug&#x02010;resistant <italic>S</italic>. <italic>aureus</italic> strains. All cannabinoids showed potent antibacterial activity, with MIC values in the 0.5&#x02013;2&#x000a0;&#x003bc;g/ml range. Also, a relation between the chemical structure of cannabinoids and the antibiotic activity was found, suggesting a specific interaction to a bacterial target.<xref rid="prp2761-bib-0072" ref-type="ref">
<sup>72</sup>
</xref> Following these results, Farha et al., 2020 proved that cannabinoids (CBC, CBD, CBG, CBN, &#x00394;9&#x02010;THC, and precursors) have potent antibacterial activity against MRSA, inhibited MRSA biofilm formation, eradicated pre&#x02010;formed biofilms and stationary phase cells persistent to antibiotics.<xref rid="prp2761-bib-0073" ref-type="ref">
<sup>73</sup>
</xref> Moreover, the endocannabinoid <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2364">anandamide</ext-link> (AEA) and the endocannabinoid&#x02010;like, arachidonoyl serine (AraS) also were able to inhibit biofilm formation, the reduced metabolic activity of pre&#x02010;formed biofilms, and altered biofilm&#x02010;associated virulence factors such as hydrophobicity, cell aggregation, and spreading ability in MRSA.<xref rid="prp2761-bib-0074" ref-type="ref">
<sup>74</sup>
</xref> Finally, recent reports demonstrated the antibacterial activity of CBD, CBDA<xref rid="prp2761-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>, and CBCA<xref rid="prp2761-bib-0076" ref-type="ref">
<sup>76</sup>
</xref> against Gram&#x02010;positive bacteria, including MRSA.</p><p>Cannabinoids showed to improve the antimicrobial activity of conventional antibiotics against resistant bacteria and vice versa, some antibiotics have enhanced and extended the antimicrobial activity of cannabinoids.<xref rid="prp2761-bib-0073" ref-type="ref">
<sup>73</sup>
</xref>, <xref rid="prp2761-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="prp2761-bib-0078" ref-type="ref">
<sup>78</sup>
</xref> CBD significantly enhanced the antibacterial effect of erythromycin and rifampicin against <italic>E. coli</italic> VCS257and increased the antibacterial effect of kanamycin against <italic>S</italic>. <italic>aureus</italic> subsp. <italic>aureus</italic> Rosenbach.<xref rid="prp2761-bib-0077" ref-type="ref">
<sup>77</sup>
</xref> CBD also potentiates the effect of bacitracin against MRSA, <italic>Enterococcus faecalis, L. monocytogenes</italic>, and Methicillin&#x02010;Resistant <italic>Staphylococcus epidermidis</italic> (MRSE) and the combination reduced de MIC value of bacitracin by at least 64&#x02010;fold. In time&#x02010;kill assays, CBD and bacitracin showed synergistic and bactericidal effects.<xref rid="prp2761-bib-0078" ref-type="ref">
<sup>78</sup>
</xref> The presence of a sublethal concentration of polymyxin B increased the activity of the five major cannabinoids against <italic>E. coli</italic>. Also, a synergy antimicrobial activity was determined between the combination of CBG and polymyxin B against multidrug&#x02010;resistant clinical isolates of Gram&#x02010;negative pathogens such as <italic>Acinetobacter baumannii, E. coli, K. pneumoniae</italic>, and <italic>P. aeruginosa</italic>.<xref rid="prp2761-bib-0073" ref-type="ref">
<sup>73</sup>
</xref> Interactions between natural antimicrobial agents (i.e. poly&#x02010;L&#x02010;lysine) and endocannabinoids and endocannabinoids&#x02010;like compounds were also reported. AEA and oleoyl ethanol amide (OEA) showed synergistic antimicrobial effect with poly&#x02010;L&#x02010;lysine against <italic>Streptococcus mutans</italic> in terms of bacterial growth. The combination of AEA and poly&#x02010;L&#x02010;lysine also showed an antibiofilm effect.<xref rid="prp2761-bib-0079" ref-type="ref">
<sup>79</sup>
</xref> However, positive interactions between pure cannabinods and conventional antibiotics are not always found. Recently, CBD showed indifference effect with the combination with different kind of antibiotics in synergy test against MRSA.<xref rid="prp2761-bib-0075" ref-type="ref">
<sup>75</sup>
</xref>
</p></sec></sec><sec id="prp2761-sec-0007"><label>4</label><title>POTENTIAL ANTIMICROBIAL MODE OF ACTION OF COMPOUNDS FROM CANNABIS</title><p>Although the antibacterial mechanism of action of cannabinoids has remained elusive, recently some advances have been made.</p><p>One of the proposed modes of action of molecules found in Cannabis is related to the alteration of membrane permeability. The terpene Limonene destroyed the cell integrity and wall structure of <italic>L. monocytogenes</italic> leading to leakage of intracellular components.<xref rid="prp2761-bib-0064" ref-type="ref">
<sup>64</sup>
</xref> &#x003b2;&#x02010;caryophyllene showed similar alterations in <italic>the B. cereus</italic> membrane.<xref rid="prp2761-bib-0058" ref-type="ref">
<sup>58</sup>
</xref> CBG also has demonstrated to target the cytoplasmic membrane of Gram&#x02010;positive bacteria. Besides, the permeabilization of the outer membrane of Gram&#x02010;negative bacteria decreased the MIC of CBG for these bacteria (from &#x0003e;128 to 1&#x000a0;&#x003bc;g/ml) and allowed CBG to act in the inner membrane similarly as in Gram&#x02010;positive bacteria.<xref rid="prp2761-bib-0073" ref-type="ref">
<sup>73</sup>
</xref> Microscopic evaluation of the effect of CBCA against <italic>B. subtilis</italic> also showed an alteration of the bacterial membrane and nucleoid, that lead to cell lysis.<xref rid="prp2761-bib-0076" ref-type="ref">
<sup>76</sup>
</xref> CBD showed a membrane&#x02010;related activity causing a depolarization of the cytoplasmatic membrane and a disruption of the membrane potential in <italic>S</italic>. <italic>aureus</italic>. Furthermore, the combination CBD with bacitracin caused defects in cell division and cell envelope irregularities apparently due to a down&#x02010;regulation of a very important cell division gene called <italic>ezrA</italic>.<xref rid="prp2761-bib-0078" ref-type="ref">
<sup>78</sup>
</xref>
</p><p>Another putative mode of action of cannabinoids is the alteration of cell communication via inhibition of membrane vesicles released by bacteria. CBD proved to be a strong inhibitor of membrane vesicle release from <italic>E. coli</italic> VCS257, although this action was insignificant in <italic>S</italic>. <italic>aureus</italic> subsp. <italic>aureus</italic> Rosenbach.<xref rid="prp2761-bib-0077" ref-type="ref">
<sup>77</sup>
</xref> In this address, the synthetic cannabinoid <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=summary%26ligandId=731">HU&#x02010;210</ext-link> also showed an effect on the bacterial communication system via inhibiting the quorum sensing (QS) system and QS&#x02010;mediated properties such as bioluminescence, biofilm formation, and swimming motility of <italic>Vibrio harveyi</italic>.<xref rid="prp2761-bib-0080" ref-type="ref">
<sup>80</sup>
</xref>
</p></sec><sec id="prp2761-sec-0008"><label>5</label><title>CANNABIS DERIVATES IN VIVO: INTERACTION WITH THE IMMUNE SYSTEM AND TOXICITY</title><p>Some concerns arise when thinking of Cannabis compounds as antimicrobials agents and they are related to in vivo efficacy, interactions with the immune system, pharmacokinetics, adverse effects, and toxicity.</p><p>To achieve a positive therapeutic outcome, drugs must reach an optimal concentration above the active threshold (the MIC for antimicrobial compounds) but below toxic levels. Furthermore, therapeutic success in antimicrobial therapies does not only depends on the MIC value, since the immunomodulation activity of the molecules also plays an important role.<xref rid="prp2761-bib-0081" ref-type="ref">
<sup>81</sup>
</xref>
</p><sec id="prp2761-sec-0009"><label>5.1</label><title>Cannabinoids and immune system</title><p>The relation between the endocannabinoid system and the immune system and the impact of exogenous cannabinoids ligands on immune function especially during infections is not completely understood.<xref rid="prp2761-bib-0082" ref-type="ref">
<sup>82</sup>
</xref> Many of the components of the endocannabinoid system have been involved in the immune system modulation through the regulation of the migration of hematopoietic stem and progenitor cells, the regulation of innate immune cell trafficking and functions, and the regulation of adaptive immunity (modulating T&#x02010;cells and B&#x02010;cells function).<xref rid="prp2761-bib-0083" ref-type="ref">
<sup>83</sup>
</xref> However, there have been discrepancies between studies that demonstrate inhibitory effects on the immune system and others reporting a stimulatory action on immune cells, probably due to the complexity in the endocannabinoid network, the heterogeneity in types of cannabinoids and their effects, methods, and protocols utilized and to a biphasic response associated to the concentration of cannabinoids (stimulatory at nanomolar concentration and inhibitory at micromolar).<xref rid="prp2761-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>
</p><p>The challenge with lipopolysaccharide (LPS) in animal models can induce rapid organic responses characterized by an overwhelming innate immune reaction that resembles some initial characteristic of sepsis.<xref rid="prp2761-bib-0084" ref-type="ref">
<sup>84</sup>
</xref> The deletion of the CB1 receptor in mice as well as the administration of a CB1 receptor antagonist has shown to prevent fever in a murine LPS model by inhibition of <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1754">Toll&#x02010;like receptor 4</ext-link> (TLR4)&#x02010;mediated cytokine production. Mice deficient for CB1 receptor had lower plasma <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4998">interleukin 6</ext-link> (IL&#x02010;6) and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5073">tumor necrosis factor &#x003b1;</ext-link> (TNF&#x02010;&#x003b1;) levels and did not exhibit hyperalgesia in response to LPS.<xref rid="prp2761-bib-0085" ref-type="ref">
<sup>85</sup>
</xref> On the contrary, CB2 receptor activation is implicated in protective anti&#x02010;inflammatory responses in mice acute sepsis models, as the administration of a CB2 synthetic agonist probed to increase the survival rate and decreased the pro&#x02010;inflammatory cytokines release in splenocytes and macrophages in LPS treated animals, and the opposite effect was observed in know&#x02010;out CB2 mice.<xref rid="prp2761-bib-0086" ref-type="ref">
<sup>86</sup>
</xref>
</p><p>In models of acute lung injury induced by LPS, Riveiro et al. reported that CBD has anti&#x02010;inflammatory effects and improved lung function,<xref rid="prp2761-bib-0087" ref-type="ref">
<sup>87</sup>
</xref>, <xref rid="prp2761-bib-0088" ref-type="ref">
<sup>88</sup>
</xref> while Karmaus et al., (2013) demonstrated that oral administration of CBD enhanced LPS&#x02010;induced pulmonary inflammation in mice.<xref rid="prp2761-bib-0089" ref-type="ref">
<sup>89</sup>
</xref>
</p><p>Ambiguous results were also noticed between the antimicrobial in vitro results (mentioned before) and the in vivo models of infection tests, which in some cases have shown negative effects.<xref rid="prp2761-bib-0090" ref-type="ref">
<sup>90</sup>
</xref> The combination of &#x00394;9&#x02010;THC with purified LPS, heat&#x02010;killed <italic>E. coli</italic>, live <italic>E. coli</italic> or lipid A&#x02010;protein complexes enhanced mortality in mice.<xref rid="prp2761-bib-0091" ref-type="ref">
<sup>91</sup>
</xref> The administration of &#x00394;9&#x02010;THC, &#x00394;8&#x02010;THC, CBD, and Cannabis extract also decreased the resistance of mice to <italic>L. monocytogenes</italic> infection in a dose&#x02010;dependent manner.<xref rid="prp2761-bib-0092" ref-type="ref">
<sup>92</sup>
</xref> In agreement with these results, several works have shown that &#x00394;9&#x02010;THC modulates the immune system and leads to a suppression of cellular function and cytokine production (specially <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4968">interferon&#x02010;&#x003b3;</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4977">interleukine 12</ext-link>) and increased mortality of mice to <italic>Legionella pneumophila</italic> infections.<xref rid="prp2761-bib-0093" ref-type="ref">
<sup>93</sup>
</xref>, <xref rid="prp2761-bib-0094" ref-type="ref">
<sup>94</sup>
</xref>, <xref rid="prp2761-bib-0095" ref-type="ref">
<sup>95</sup>
</xref> However, the effect of cannabinoids on the levels of the proinflammatory cytokine has proven to have a beneficial effect on animal models of infection. In an animal model of meningitis, the administration of CBD (10&#x000a0;mg/kg) for nine days after the challenge with <italic>Streptococcus pneumoniae</italic> prevented the memory impairment in rats.<xref rid="prp2761-bib-0096" ref-type="ref">
<sup>96</sup>
</xref> Besides, similar protective effects were seen in a sepsis animal model by cecal ligation and puncture, where CBD treatment improved impaired cognitive functions and decreased mortality of rats.<xref rid="prp2761-bib-0097" ref-type="ref">
<sup>97</sup>
</xref> In a murine systemic model of infection of MRSA, Farha et al. reported that CBG showed a significant reduction in bacterial burden in the spleen at a dose of 100&#x000a0;mg/kg, comparable to vancomycin at similar doses.<xref rid="prp2761-bib-0073" ref-type="ref">
<sup>73</sup>
</xref>
</p></sec><sec id="prp2761-sec-0010"><label>5.2</label><title>Cannabinoids toxicity</title><p>Toxicity is probably the first limitation on cannabinoids uses. In animal models, high doses of THC produced hypothermia, hypo locomotion, catalepsy, and antinociception.<xref rid="prp2761-bib-0098" ref-type="ref">
<sup>98</sup>
</xref> In rats, the median lethal dose (LD<sub>50</sub>) of &#x00394;9&#x02010;THC administered orally was estimated between 800 and 1900&#x000a0;mg/kg, however in dogs and monkeys doses up to 3000 and 9000&#x000a0;mg/kg respectively were nonlethal.<xref rid="prp2761-bib-0099" ref-type="ref">
<sup>99</sup>
</xref> CBD, CBG, CBC, &#x00394;9&#x02010;Tetrahydrocannabivarin (&#x00394;9&#x02010;THCV), CBDV and the acids forms of cannabinoids have shown weak or non&#x02010;psychoactivity thus they are more well&#x02010;tolerated.<xref rid="prp2761-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> Pharmacokinetic studies in mice and rats were performed with single doses of cannabinoids, given intraperitoneally and orally at doses of 120&#x000a0;mg/kg (CBD and CBG), 60&#x000a0;mg/kg (CBDV), and 30&#x000a0;mg/kg (&#x00394;9&#x02010;THCV) with no signs of acute toxicity.<xref rid="prp2761-bib-0100" ref-type="ref">
<sup>100</sup>
</xref> In dogs, escalated doses of CBD up to 62&#x000a0;mg/kg proved to be safe with only some mild adverse events (mainly gastrointestinal) comparable to the placebo group.<xref rid="prp2761-bib-0101" ref-type="ref">
<sup>101</sup>
</xref> In humans, chronic use of CBD with doses up to 1500&#x000a0;mg/day were reported to be well tolerated.<xref rid="prp2761-bib-0102" ref-type="ref">
<sup>102</sup>
</xref> A report from the WHO Expert Committee on Drug Dependence concluded that &#x0201c;CBD" is generally well tolerated and to have a good safety profile&#x0201d;, and that &#x0201c;CBD should not be scheduled within the International Drug Control Conventions&#x0201d;.<xref rid="prp2761-bib-0103" ref-type="ref">
<sup>103</sup>
</xref>
</p></sec></sec><sec sec-type="conclusions" id="prp2761-sec-0011"><label>6</label><title>CONCLUSION</title><p>The bacterial resistance to conventional chemical antibiotics has led to the search for new alternative antimicrobial agents and strategies. Many plant extracts and their purified compounds have shown antimicrobial activity to a wide variety of pathogens.</p><p>Cannabinoids and related compounds from <italic>C</italic>. <italic>sativa</italic> exhibit numerous attractive pharmacological properties. Many of them have been extensively explored while others, such as the potential of Cannabis extracts and compounds as antibacterial agents, are still in a very early stage.</p><p>In vitro studies have shown that Cannabis extracts and EOs exert antimicrobial properties. There have been variable results in the spectrum of activity of Cannabis products probably due to variability in the extracts assayed and in the microbiological test utilized. It should having into account that most of the reports mentioned in this review, specially those using cannabis extracts, are a mixture of compounds not fully analytical assessed. In addition, on a microbiological point of view some conclusion were made based on diffusion technique methods that needs to be further complemented by dilution techniques. In general, Cannabis extracts and purified cannabinoids have proven to be more active against Gram&#x02010;positive bacteria, including multidrug&#x02010;resistant microorganisms. Cannabinoids have also exhibited antimicrobial effects against yeast and some Gram&#x02010;negative bacteria. Further, cannabinoids have also shown synergistic interaction enhancing the antibacterial effect of conventional antibiotics in vitro. This finding makes cannabinoids good candidates for the development of antimicrobial combined therapies to improve the outcome of the treatment of resistant bacteria.</p><p>The role of the endocannabinoid system in infectious diseases and the effects of the administration of cannabinoids compounds in pre&#x02010;clinic models of infections still needs to be elucidated. Considering the results previously mentioned, it seems that cannabinoids (specially &#x00394;9&#x02010;THC) could compromise the immune system and make it ineffective against intracellular microorganisms but cannabinoids could be useful to protect from the attack of extracellular bacteria and the damage of excessive immune response in bacterial infections.</p><p>Although some advances have been made and several bacterial targets have been postulated, cannabinoids and terpenes specific antimicrobial mode of action still needs a better understanding.</p><p>Finally, the concerns on toxicity and adverse effects of the use of Cannabis extracts (in particular those which are highly concentrated in &#x00394;9&#x02010;THC) could be left behind by using non&#x02010;psychotropic cannabinoids, that has proven a safety profile in animal models and potent in vitro antibacterial activity.</p><p>All the data presented in this work suggests that cannabinoids and other Cannabis components demonstrated some outstanding in vitro antibacterial features that should be further tested in vivo against clinically important bacteria in the search of new tools as potential antimicrobial agents.</p></sec><sec id="prp2761-sec-0012"><title>NOMENCLATURE OF TARGETS AND LIGANDS</title><p>Key protein targets and ligands in this article are hyperlinked to corresponding entries in <ext-link ext-link-type="uri" xlink:href="http://www.guidetopharmacology.org">http://www.guidetopharmacology.org</ext-link>, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY,<xref rid="prp2761-bib-0104" ref-type="ref">
<sup>104</sup>
</xref> and are permanently archived in the Concise Guide to PHARMACOLOGY 2019/20.<xref rid="prp2761-bib-0105" ref-type="ref">
<sup>105</sup>
</xref>
</p></sec><sec sec-type="COI-statement" id="prp2761-sec-0013"><title>DISCLOSURE</title><p>None to declare.</p></sec></body><back><sec sec-type="data-availability" id="prp2761-sec-0015"><title>DATA AVAILABILITY STATEMENT</title><p>None to declare.</p></sec><ref-list content-type="cited-references" id="prp2761-bibl-0001"><title>REFERENCES</title><ref id="prp2761-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="prp2761-cit-0001">
<string-name>
<surname>Martens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Demain</surname>
<given-names>AL</given-names>
</string-name>. <article-title>The antibiotic resistance crisis, with a focus on the United States</article-title>. <source xml:lang="en">J Antibiot</source>. <year>2017</year>;<volume>70</volume>(<issue>5</issue>):<fpage>520</fpage>&#x02010;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2017.30</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="prp2761-cit-0002">
<string-name>
<surname>Levy</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>B</given-names>
</string-name>. <article-title>Antibacterial resistance worldwide: causes, challenges and responses</article-title>. <source xml:lang="en">Nat Med</source>. <year>2004</year>;<volume>10</volume>(<issue>12 Suppl</issue>):<fpage>S122</fpage>&#x02010;<lpage>S129</lpage>. <pub-id pub-id-type="doi">10.1038/nm1145</pub-id>
<pub-id pub-id-type="pmid">15577930</pub-id></mixed-citation></ref><ref id="prp2761-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="prp2761-cit-0003">
<string-name>
<surname>Andrei</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Valeanu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chirvasuta</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stefan</surname>
<given-names>MG</given-names>
</string-name>. <article-title>New FDA approved antibacterial drugs: 2015&#x02013;2017</article-title>. <source xml:lang="en">Discoveries</source>. <year>2018</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e81</fpage>. <pub-id pub-id-type="doi">10.15190/d.2018.1</pub-id>
<pub-id pub-id-type="pmid">32309599</pub-id></mixed-citation></ref><ref id="prp2761-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="prp2761-cit-0004">
<string-name>
<surname>Rios</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Moutinho</surname>
<given-names>CG</given-names>
</string-name>, <string-name>
<surname>Pinto</surname>
<given-names>FC</given-names>
</string-name>, et al. <article-title>Alternatives to overcoming bacterial resistances: state&#x02010;of&#x02010;the&#x02010;art</article-title>. <source xml:lang="en">Microbiol Res</source>. <year>2016</year>;<volume>191</volume>:<fpage>51</fpage>&#x02010;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2016.04.008</pub-id>
<pub-id pub-id-type="pmid">27524653</pub-id></mixed-citation></ref><ref id="prp2761-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="prp2761-cit-0005">
<string-name>
<surname>Nascimento</surname>
<given-names>GGF</given-names>
</string-name>, <string-name>
<surname>Freitas</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>GL</given-names>
</string-name>. <article-title>Antibacterial activity of plant extracts and phytochemicals on antibiotic&#x02010;resistant bacteria</article-title>. <source xml:lang="en">Braz J Microbiol</source>. <year>2000</year>;<volume>31</volume>(<issue>4</issue>):<fpage>247</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1590/s1517-83822000000400003</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="prp2761-cit-0006">
<string-name>
<surname>Atef</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Shanab</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Negm</surname>
<given-names>SI</given-names>
</string-name>, <string-name>
<surname>Abbas</surname>
<given-names>YA</given-names>
</string-name>. <article-title>Evaluation of the antimicrobial activity of some plant extracts against antibiotic susceptible and resistant bacterial strains causing wound infection</article-title>. <source xml:lang="en">Bull Natl Res Cent</source>. <year>2019</year>;<volume>43</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.1186/s42269-019-0184-9</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="prp2761-cit-0007">
<string-name>
<surname>Choi</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>OH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YS</given-names>
</string-name>, et al. <article-title>In vitro and in vivo antibacterial activity of <italic>Punica granatum</italic> peel ethanol extract against salmonella</article-title>. <source xml:lang="en">Evid&#x02010;Based ComplAlt</source>. <year>2011</year>;<fpage>1</fpage>&#x02010;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/ecam/nep105</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="prp2761-cit-0008">
<string-name>
<surname>Yunana</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Bukar</surname>
<given-names>BB</given-names>
</string-name>, <string-name>
<surname>Aguiyi</surname>
<given-names>JC</given-names>
</string-name>. <article-title>In vitro and in vivo evaluation of antibacterial activity of <italic>Bridelia ferruginea</italic> extracts on some clinical isolates</article-title>. <source xml:lang="en">J Phytopharmacol</source>. <year>2018</year>;<volume>7</volume>(<issue>4</issue>):<fpage>392</fpage>&#x02010;<lpage>398</lpage>.</mixed-citation></ref><ref id="prp2761-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="prp2761-cit-0009">
<string-name>
<surname>Wagner</surname>
<given-names>H</given-names>
</string-name>. <article-title>Synergy research: approaching a new generation of phytopharmaceuticals</article-title>. <source xml:lang="en">Fitoterapia</source>. <year>2011</year>;<volume>82</volume>(<issue>1</issue>):<fpage>34</fpage>&#x02010;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2010.11.016</pub-id>
<pub-id pub-id-type="pmid">21075177</pub-id></mixed-citation></ref><ref id="prp2761-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="prp2761-cit-0010">
<string-name>
<surname>Bonini</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Premoli</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tambaro</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>
<italic>Cannabis sativa</italic>: a comprehensive ethnopharmacological review of a medicinal plant with a long history</article-title>. <source xml:lang="en">J Ethnopharmacol</source>. <year>2018</year>;<volume>227</volume>:<fpage>300</fpage>&#x02010;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.09.004</pub-id>
<pub-id pub-id-type="pmid">30205181</pub-id></mixed-citation></ref><ref id="prp2761-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="prp2761-cit-0011">
<string-name>
<surname>Zuardi</surname>
<given-names>AW</given-names>
</string-name>. <article-title>History of cannabis as a medicine: a review</article-title>. <source xml:lang="en">Braz J Psychiatry</source>. <year>2006</year>;<volume>28</volume>(<issue>2</issue>):<fpage>153</fpage>&#x02010;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1590/s1516-44462006000200015</pub-id>
<pub-id pub-id-type="pmid">16810401</pub-id></mixed-citation></ref><ref id="prp2761-bib-0012"><label>12</label><mixed-citation publication-type="book" id="prp2761-cit-0012">
<string-name>
<surname>Russo</surname>
<given-names>EB</given-names>
</string-name>. <chapter-title>The pharmacological history of Cannabis</chapter-title>. In: <person-group person-group-type="editor"><string-name>
<surname>Pertwee</surname>
<given-names>R</given-names>
</string-name></person-group>, ed. <source xml:lang="en">Handbook of cannabinoids</source>. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford Univ. Press</publisher-name>; <year>2014</year>.</mixed-citation></ref><ref id="prp2761-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="prp2761-cit-0013">
<string-name>
<surname>Russo</surname>
<given-names>EB</given-names>
</string-name>. <article-title>History of cannabis and its preparations in saga, science, and sobriquet</article-title>. <source xml:lang="en">Chem Biodivers</source>. <year>2007</year>;<volume>4</volume>(<issue>8</issue>):<fpage>1614</fpage>&#x02010;<lpage>1648</lpage>. <pub-id pub-id-type="doi">10.1002/cbdv.200790144</pub-id>
<pub-id pub-id-type="pmid">17712811</pub-id></mixed-citation></ref><ref id="prp2761-bib-0014"><label>14</label><mixed-citation publication-type="book" id="prp2761-cit-0014">
<string-name>
<surname>Russo</surname>
<given-names>EB</given-names>
</string-name>. <chapter-title>Cannabis in India: ancient lore and modern medicine</chapter-title>. In: <person-group person-group-type="editor"><string-name>
<surname>Mechoulam</surname>
<given-names>R</given-names>
</string-name></person-group>, ed. <source xml:lang="en">Cannabinoids as therapeutics</source>. <publisher-loc>Basel</publisher-loc>: <publisher-name>Birkh&#x000e4;user Verlag</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="prp2761-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="prp2761-cit-0015">
<string-name>
<surname>Kabel&#x000ed;k</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Krejc&#x000ed;</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Santavy</surname>
<given-names>F</given-names>
</string-name>. <article-title>Cannabis as a medicament</article-title>. <source xml:lang="en">Bull Narc</source>. <year>1960</year>;<volume>12</volume>:<fpage>5</fpage>&#x02010;<lpage>23</lpage>.</mixed-citation></ref><ref id="prp2761-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="prp2761-cit-0016">
<string-name>
<surname>Takakuwa</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Schears</surname>
<given-names>RM</given-names>
</string-name>. <article-title>A history of the US medical cannabis movement and its importance to pediatricians: science versus politics in medicine&#x02019;s greatest catch&#x02010;22</article-title>. <source xml:lang="en">Clin Pediatr</source>. <year>2019</year>;<volume>58</volume>(<issue>14</issue>):<fpage>1473</fpage>&#x02010;<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1177/0009922819875550</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="prp2761-cit-0017">
<string-name>
<surname>Pertwee</surname>
<given-names>RG</given-names>
</string-name>. <article-title>Cannabinoid pharmacology: the first 66 years</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2006</year>;<volume>147</volume>(<issue>S1</issue>):<fpage>S163</fpage>&#x02010;<lpage>S171</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706406</pub-id>
<pub-id pub-id-type="pmid">16402100</pub-id></mixed-citation></ref><ref id="prp2761-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="prp2761-cit-0018">
<string-name>
<surname>Izzo</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Borrelli</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Capasso</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Di Marzo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Mechoulam</surname>
<given-names>R</given-names>
</string-name>. <article-title>Non&#x02010;psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb</article-title>. <source xml:lang="en">Trends Pharmacol Sci</source>. <year>2009</year>;<volume>30</volume>(<issue>10</issue>):<fpage>515</fpage>&#x02010;<lpage>527</lpage>.<pub-id pub-id-type="pmid">19729208</pub-id></mixed-citation></ref><ref id="prp2761-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="prp2761-cit-0019">
<string-name>
<surname>Hanus</surname>
<given-names>LO</given-names>
</string-name>. <article-title>Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids</article-title>. <source xml:lang="en">Med Res Rev</source>. <year>2009</year>;<volume>29</volume>(<issue>2</issue>):<fpage>213</fpage>&#x02010;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1002/med.20135</pub-id>
<pub-id pub-id-type="pmid">18777572</pub-id></mixed-citation></ref><ref id="prp2761-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="prp2761-cit-0020">
<string-name>
<surname>ElSohly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Radwan</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Gul</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chandra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Galal</surname>
<given-names>A</given-names>
</string-name>. <article-title>phytochemistry of <italic>Cannabis sativa</italic> L</article-title>. <source xml:lang="en">Prog Chem Org Nat Prod</source>. <year>2017</year>;<volume>103</volume>:<fpage>1</fpage>&#x02010;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-45541-9_1</pub-id>
<pub-id pub-id-type="pmid">28120229</pub-id></mixed-citation></ref><ref id="prp2761-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="prp2761-cit-0021">
<string-name>
<surname>Flores&#x02010;Sanchez</surname>
<given-names>IJ</given-names>
</string-name>, <string-name>
<surname>Verpoorte</surname>
<given-names>R</given-names>
</string-name>. <article-title>Secondary metabolism in cannabis</article-title>. <source xml:lang="en">Phytochem Rev</source>. <year>2008</year>;<volume>7</volume>:<fpage>615</fpage>&#x02010;<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1007/s11101-008-9094-4</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="prp2761-cit-0022">
<string-name>
<surname>Ligresti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>De Petrocellis</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Di Marzo</surname>
<given-names>V</given-names>
</string-name>. <article-title>From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology</article-title>. <source xml:lang="en">Physiol Rev</source>. <year>2016</year>;<volume>96</volume>(<issue>4</issue>):<fpage>1593</fpage>&#x02010;<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00002.2016</pub-id>
<pub-id pub-id-type="pmid">27630175</pub-id></mixed-citation></ref><ref id="prp2761-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="prp2761-cit-0023">
<string-name>
<surname>Elsohly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Slade</surname>
<given-names>D</given-names>
</string-name>. <article-title>Chemical constituents of marijuana: the complex mixture of natural cannabinoids</article-title>. <source xml:lang="en">Life Sci</source>. <year>2005</year>;<volume>78</volume>(<issue>5</issue>):<fpage>539</fpage>&#x02010;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.011</pub-id>
<pub-id pub-id-type="pmid">16199061</pub-id></mixed-citation></ref><ref id="prp2761-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="prp2761-cit-0024">
<string-name>
<surname>Andre</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Hausman</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Guerriero</surname>
<given-names>G</given-names>
</string-name>. <article-title>
<italic>Cannabis sativa</italic>: the plant of the thousand and one molecule</article-title>. <source xml:lang="en">Front Plant Sci</source>. <year>2016</year>;<volume>7</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.3389/fpls.2016.00019</pub-id>
<pub-id pub-id-type="pmid">26870049</pub-id></mixed-citation></ref><ref id="prp2761-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="prp2761-cit-0025">
<string-name>
<surname>Taura</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sirikantaramas</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Shoyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shoyama</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Morimoto</surname>
<given-names>S</given-names>
</string-name>. <article-title>Phytocannabinoids in <italic>Cannabis sativa</italic>: recent studies on biosynthetic enzymes</article-title>. <source xml:lang="en">Chem Biodivers</source>. <year>2007</year>;<volume>4</volume>(<issue>8</issue>):<fpage>1649</fpage>&#x02010;<lpage>1663</lpage>. <pub-id pub-id-type="doi">10.1002/cbdv.200790145</pub-id>
<pub-id pub-id-type="pmid">17712812</pub-id></mixed-citation></ref><ref id="prp2761-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="prp2761-cit-0026">
<string-name>
<surname>Turner</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Elsohly</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Biological activity of cannabichromene, its homologs and isomers</article-title>. <source xml:lang="en">J Clin Pharmacol</source>. <year>1981</year>;<volume>21</volume>(<issue>S1</issue>):<fpage>283S</fpage>&#x02010;<lpage>291S</lpage>. <pub-id pub-id-type="doi">10.1002/j.1552-4604.1981.tb02606.x</pub-id>
<pub-id pub-id-type="pmid">7298870</pub-id></mixed-citation></ref><ref id="prp2761-bib-0027"><label>27</label><mixed-citation publication-type="book" id="prp2761-cit-0027">
<string-name>
<surname>Sirikantaramas</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Taura</surname>
<given-names>F</given-names>
</string-name>. <chapter-title>Cannabinoids: biosynthesis and biotechnological applications</chapter-title>. In: <person-group person-group-type="editor"><string-name>
<surname>Chandra</surname>
<given-names>S</given-names>
</string-name></person-group>, <person-group person-group-type="editor"><string-name>
<surname>Lata</surname>
<given-names>H</given-names>
</string-name></person-group>, <person-group person-group-type="editor"><string-name>
<surname>ElSohly</surname>
<given-names>M</given-names>
</string-name></person-group>, eds. <source xml:lang="en"><italic toggle="yes">Cannabis sativa</italic> L. &#x02010; Botany and Biotechnology</source>. <publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2017</year>. <pub-id pub-id-type="doi">10.1007/978-3-319-54564-6_8</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="prp2761-cit-0028">
<string-name>
<surname>Russo</surname>
<given-names>EB</given-names>
</string-name>. <article-title>Taming THC: potential cannabis synergy and phytocannabinoid&#x02010;terpenoid entourage effects</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2011</year>;<volume>163</volume>(<issue>7</issue>):<fpage>1344</fpage>&#x02010;<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01238.x</pub-id>
<pub-id pub-id-type="pmid">21749363</pub-id></mixed-citation></ref><ref id="prp2761-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="prp2761-cit-0029">
<string-name>
<surname>Gaoni</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Mechoulam</surname>
<given-names>R</given-names>
</string-name>. <article-title>Isolation, structure, and partial synthesis of an active constituent of Hashish</article-title>. <source xml:lang="en">J Am Chem Soc</source>. <year>1964</year>;<volume>86</volume>(<issue>8</issue>):<fpage>1646</fpage>&#x02010;<lpage>1647</lpage>. <pub-id pub-id-type="doi">10.1021/ja01062a046</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0030"><label>30</label><mixed-citation publication-type="book" id="prp2761-cit-0030">
<string-name>
<surname>Hartsel</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Eades</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hickory</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Makriyannis</surname>
<given-names>A</given-names>
</string-name>. <chapter-title>Chapter 53&#x02014;<italic>Cannabis sativa</italic> and hemp</chapter-title>. In: <person-group person-group-type="editor"><string-name>
<surname>Gupta</surname>
<given-names>RC</given-names>
</string-name></person-group>, ed. <source xml:lang="en">Nutraceuticals</source>. <publisher-name>Academic Press</publisher-name>; <year>2016</year>:<fpage>735</fpage>&#x02010;<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-802147-7.00053-X</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="prp2761-cit-0031">
<string-name>
<surname>Pertwee</surname>
<given-names>RG</given-names>
</string-name>. <article-title>The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9&#x02010;tetrahydrocannabinol, cannabidiol and delta9&#x02010;tetrahydrocannabivarin</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2008</year>;<volume>153</volume>(<issue>2</issue>):<fpage>199</fpage>&#x02010;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0707442</pub-id>
<pub-id pub-id-type="pmid">17828291</pub-id></mixed-citation></ref><ref id="prp2761-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="prp2761-cit-0032">
<string-name>
<surname>Hanu&#x00161;</surname>
<given-names>LO</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Mu&#x000f1;oz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Taglialatela&#x02010;Scafati</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Appendino</surname>
<given-names>G</given-names>
</string-name>. <article-title>Phytocannabinoids: a unified critical inventory</article-title>. <source xml:lang="en">Nat Prod Rep</source>. <year>2016</year>;<volume>33</volume>(<issue>12</issue>):<fpage>1357</fpage>&#x02010;<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1039/c6np00074f</pub-id>
<pub-id pub-id-type="pmid">27722705</pub-id></mixed-citation></ref><ref id="prp2761-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="prp2761-cit-0033">
<string-name>
<surname>Udoh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Santiago</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Devenish</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>McGregor</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Connor</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cannabichromene is a cannabinoid CB<sub>2</sub> receptor agonist</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2019</year>;<volume>176</volume>(<issue>23</issue>):<fpage>4537</fpage>&#x02010;<lpage>4547</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14815</pub-id>
<pub-id pub-id-type="pmid">31368508</pub-id></mixed-citation></ref><ref id="prp2761-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="prp2761-cit-0034">
<string-name>
<surname>Appendino</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chianese</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Taglialatela&#x02010;Scafati</surname>
<given-names>O</given-names>
</string-name>. <article-title>Cannabinoids: occurrence and medicinal chemistry</article-title>. <source xml:lang="en">Curr Med Chem</source>. <year>2011</year>;<volume>18</volume>(<issue>7</issue>):<fpage>1085</fpage>&#x02010;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.2174/092986711794940888</pub-id>
<pub-id pub-id-type="pmid">21254969</pub-id></mixed-citation></ref><ref id="prp2761-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="prp2761-cit-0035">
<string-name>
<surname>Pisanti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Malfitano</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Ciaglia</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>Cannabidiol: state of the art and new challenges for therapeutic applications</article-title>. <source xml:lang="en">Pharmacol Ther</source>. <year>2017</year>;<volume>175</volume>:<fpage>133</fpage>&#x02010;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.02.041</pub-id>
<pub-id pub-id-type="pmid">28232276</pub-id></mixed-citation></ref><ref id="prp2761-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="prp2761-cit-0036">
<string-name>
<surname>Shapira</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Berman</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Futoran</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Guberman</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Meiri</surname>
<given-names>D</given-names>
</string-name>. <article-title>Tandem mass spectrometric quantification of 93 terpenoids in <italic>Cannabis</italic> using static headspace injections</article-title>. <source xml:lang="en">Anal Chem</source>. <year>2019</year>;<volume>91</volume>(<issue>17</issue>):<fpage>11425</fpage>&#x02010;<lpage>11432</lpage>. <pub-id pub-id-type="doi">10.1021/acs.analchem.9b02844</pub-id>
<pub-id pub-id-type="pmid">31369251</pub-id></mixed-citation></ref><ref id="prp2761-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="prp2761-cit-0037">
<string-name>
<surname>Chandra</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Bishnoi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yadav</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Patni</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mishra</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Nautiyal</surname>
<given-names>AR</given-names>
</string-name>. <article-title>Antimicrobial resistance and the alternative resources with special emphasis on plant&#x02010;based antimicrobials&#x02010; a review</article-title>. <source xml:lang="en">Plants</source>. <year>2017</year>;<volume>6</volume>(<issue>2</issue>):<fpage>16</fpage>. <pub-id pub-id-type="doi">10.3390/plants6020016</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="prp2761-cit-0038">
<string-name>
<surname>Turner</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Elsohly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Boeren</surname>
<given-names>EG</given-names>
</string-name>. <article-title>Constituents of <italic>Cannabis sativa</italic> L. XVII. A review of the natural constituents</article-title>. <source xml:lang="en">J Nat Prod</source>. <year>1980</year>;<volume>43</volume>(<issue>2</issue>):<fpage>169</fpage>&#x02010;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1021/np50008a001</pub-id>
<pub-id pub-id-type="pmid">6991645</pub-id></mixed-citation></ref><ref id="prp2761-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="prp2761-cit-0039">
<string-name>
<surname>Novak</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zitterl&#x02010;Eglseer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Deans</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Franz</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Essential oils of different cultivars of <italic>Cannabis sativa</italic> L. and their antimicrobial activity</article-title>. <source xml:lang="en">Flavour Fragr. J</source>. <year>2001</year>;<volume>16</volume>(<issue>4</issue>):<fpage>259</fpage>&#x02010;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1002/ffj.993</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="prp2761-cit-0040">
<string-name>
<surname>Nissen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zatta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stefanini</surname>
<given-names>I</given-names>
</string-name>, et al. <article-title>Characterization and antimicrobial activity of essential oils of industrial hemp varieties (<italic>Cannabis sativa</italic> L.)</article-title>. <source xml:lang="en">Fitoterapia</source>. <year>2010</year>;<volume>81</volume>(<issue>5</issue>):<fpage>413</fpage>&#x02010;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2009.11.010</pub-id>
<pub-id pub-id-type="pmid">19969046</pub-id></mixed-citation></ref><ref id="prp2761-bib-0041"><label>41</label><mixed-citation publication-type="book" id="prp2761-cit-0041">
<string-name>
<surname>Potter</surname>
<given-names>DJ</given-names>
</string-name>. <source xml:lang="en">The propagation, characterization and optimization of <italic toggle="yes">Cannabis sativa</italic> L. as a phytopharmaceutical</source>. Ph.D., <publisher-loc>London</publisher-loc>: <publisher-name>King's College</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="prp2761-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="prp2761-cit-0042">
<string-name>
<surname>Richins</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Rodriguez&#x02010;Uribe</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lowe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ferral</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>O'Connell</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Accumulation of bioactive metabolites in cultivated medical Cannabis</article-title>. <source xml:lang="en">PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>7</issue>):<elocation-id>e0201119</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0201119</pub-id>
<pub-id pub-id-type="pmid">30036388</pub-id></mixed-citation></ref><ref id="prp2761-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="prp2761-cit-0043">
<string-name>
<surname>Khan</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Warner</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>. <article-title>Antibacterial properties of hemp and other natural fibre plants: a review</article-title>. <source xml:lang="en">Bio Res</source>. <year>2014</year>;<volume>9</volume>(<issue>2</issue>):<fpage>3642</fpage>&#x02013;<lpage>3659</lpage>. <pub-id pub-id-type="doi">10.15376/biores.9.2.3642-3659</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="prp2761-cit-0044">
<string-name>
<surname>Wasim</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Haq</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Ashraf</surname>
<given-names>M</given-names>
</string-name>. <article-title>Antimicrobial studies of the leaf of <italic>Cannabis sativa</italic> L</article-title>. <source xml:lang="en">Pak J Pharm Sci</source>. <year>1995</year>;<volume>8</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02010;<lpage>38</lpage>.<pub-id pub-id-type="pmid">16414764</pub-id></mixed-citation></ref><ref id="prp2761-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="prp2761-cit-0045">
<string-name>
<surname>Borchardt</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Wyse</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Sheaffer</surname>
<given-names>CC</given-names>
</string-name>, et al. <article-title>Antimicrobial activity of native and naturalized plants of Minnesota and Wisconsin</article-title>. <source xml:lang="en">J Med Plant Res</source>. <year>2008</year>;<volume>2</volume>(<issue>5</issue>):<fpage>98</fpage>&#x02010;<lpage>110</lpage>.</mixed-citation></ref><ref id="prp2761-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="prp2761-cit-0046">
<string-name>
<surname>Ali</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Almagboul</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Khogali</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gergeir</surname>
<given-names>U</given-names>
</string-name>. <article-title>Antimicrobial activity of <italic>Cannabis sativa</italic> L</article-title>. <source xml:lang="en">Chin Med</source>. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>61</fpage>&#x02010;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.4236/cm.2012.31010</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="prp2761-cit-0047">
<string-name>
<surname>Lone</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Lone</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Extraction of cannabinoids from <italic>Cannabis sativa L</italic> plant and its potential antimicrobial activity</article-title>. <source xml:lang="en">Univ J Med Dent</source>. <year>2012</year>;<volume>1</volume>(<issue>4</issue>):<fpage>51</fpage>&#x02010;<lpage>55</lpage>.</mixed-citation></ref><ref id="prp2761-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="prp2761-cit-0048">
<string-name>
<surname>Kaur</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chaudhry</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Aman</surname>
<given-names>R</given-names>
</string-name>. <article-title>Antimicrobial potential of three common weeds of kurukshetra: an in vitro study</article-title>. <source xml:lang="en">Res J Microbiol</source>. <year>2015</year>;<volume>10</volume>:<fpage>280</fpage>&#x02010;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.3923/jm.2015.280.287</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="prp2761-cit-0049">
<string-name>
<surname>Isahq</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Afridi</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hussain</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Ahmad</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kanwal</surname>
<given-names>F</given-names>
</string-name>. <article-title>Proximate composition, phytochemical screening, GC&#x02010;MS studies of biologically active cannabinoids and antimicrobial activities of <italic>Cannabis indica</italic>
</article-title>. <source xml:lang="en">Asian Pac J Trop Dis</source>. <year>2015</year>;<volume>5</volume>(<issue>11</issue>):<fpage>897</fpage>&#x02010;<lpage>902</lpage>. <pub-id pub-id-type="doi">10.1016/s2222-1808(15)60953-7</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="prp2761-cit-0050">
<string-name>
<surname>Chakraborty</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Afaq</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Majumdar</surname>
<given-names>S</given-names>
</string-name>. <article-title>Antimicrobial activity of <italic>Cannabis sativa, Thuja orientalis</italic> and <italic>Psidium guajava</italic> leaf extracts against methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic>
</article-title>. <source xml:lang="en">J Integr Med</source>. <year>2018</year>;<volume>16</volume>(<issue>5</issue>):<fpage>350</fpage>&#x02010;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.joim.2018.07.005</pub-id>
<pub-id pub-id-type="pmid">30120078</pub-id></mixed-citation></ref><ref id="prp2761-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="prp2761-cit-0051">
<string-name>
<surname>Frassinetti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gabriele</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Moccia</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Longo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Di Gioia</surname>
<given-names>D</given-names>
</string-name>. <article-title>Antimicrobial and antibiofilm activity of <italic>Cannabis sativa</italic> L. seeds extract against <italic>Staphylococcus aureus</italic> and growth effects on probiotic <italic>Lactobacillus</italic> spp</article-title>. <source xml:lang="en">LWT</source>. <year>2020</year>;<volume>124</volume>:<fpage>109149</fpage>. <pub-id pub-id-type="doi">10.1016/j.lwt.2020.109149</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="prp2761-cit-0052">
<string-name>
<surname>Gallucci</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Oliva</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Casero</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Antimicrobial combined action of terpenes against the food&#x02010;borne microorganisms <italic>Escherichia coli, Staphylococcus aureus</italic> and <italic>Bacillus cereus</italic>
</article-title>. <source xml:lang="en">Flavour Fragr J</source>. <year>2009</year>;<volume>24</volume>(<issue>6</issue>):<fpage>348</fpage>&#x02010;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1002/ffj.1948</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="prp2761-cit-0053">
<string-name>
<surname>Iseppi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Brighenti</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Licata</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Chemical characterization and evaluation of the antibacterial activity of essential oils from fibre&#x02010;type <italic>Cannabis sativa</italic> L. (Hemp)</article-title>. <source xml:lang="en">Molecules</source>. <year>2019</year>;<volume>24</volume>(<issue>12</issue>):<fpage>2302</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24122302</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="prp2761-cit-0054">
<string-name>
<surname>Dahham</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Tabana</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Iqbal</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>The anticancer, antioxidant and antimicrobial properties of the sesquiterpene &#x003b2;&#x02010;caryophyllene from the essential oil of <italic>Aquilaria crassna</italic>
</article-title>. <source xml:lang="en">Molecules</source>. <year>2015</year>;<volume>20</volume>(<issue>7</issue>):<fpage>11808</fpage>&#x02010;<lpage>11829</lpage>. <pub-id pub-id-type="doi">10.3390/molecules200711808</pub-id>
<pub-id pub-id-type="pmid">26132906</pub-id></mixed-citation></ref><ref id="prp2761-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="prp2761-cit-0055">
<string-name>
<surname>Su</surname>
<given-names>YC</given-names>
</string-name>, <string-name>
<surname>Ho</surname>
<given-names>CL</given-names>
</string-name>. <article-title>Composition of the leaf essential oil of <italic>Phoebe formosana</italic> from Taiwan and its in vitro cytotoxic, antibacterial, and antifungal activities</article-title>. <source xml:lang="en">Nat Prod Commun</source>. <year>2016</year>;<volume>11</volume>(<issue>6</issue>):<fpage>845</fpage>&#x02010;<lpage>848</lpage>.<pub-id pub-id-type="pmid">27534132</pub-id></mixed-citation></ref><ref id="prp2761-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="prp2761-cit-0056">
<string-name>
<surname>Pieri</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Souza</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Vermelho</surname>
<given-names>LL</given-names>
</string-name>, et al. <article-title>Use of &#x003b2;&#x02010;caryophyllene to combat bacterial dental plaque formation in dogs</article-title>. <source xml:lang="en">BMC Vet Res</source>. <year>2016</year>;<volume>12</volume>(<issue>1</issue>):<fpage>216</fpage>. <pub-id pub-id-type="doi">10.1186/s12917-016-0842-1</pub-id>
<pub-id pub-id-type="pmid">27716286</pub-id></mixed-citation></ref><ref id="prp2761-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="prp2761-cit-0057">
<string-name>
<surname>Selestino Neta</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Vittorazzi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Guimar&#x000e3;es</surname>
<given-names>AC</given-names>
</string-name>, et al. <article-title>Effects of &#x003b2;&#x02010;caryophyllene and <italic>Murraya paniculata</italic> essential oil in the murine hepatoma cells and in the bacteria and fungi 24&#x02010;h time&#x02010;kill curve studies</article-title>. <source xml:lang="en">Pharm Biol</source>. <year>2017</year>;<volume>55</volume>(<issue>1</issue>):<fpage>190</fpage>&#x02010;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2016.1254251</pub-id>
<pub-id pub-id-type="pmid">27927082</pub-id></mixed-citation></ref><ref id="prp2761-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="prp2761-cit-0058">
<string-name>
<surname>Moo</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Osman</surname>
<given-names>MA</given-names>
</string-name>, et al. <article-title>Antibacterial activity and mode of action of &#x003b2;&#x02010;caryophyllene on <italic>Bacillus cereus</italic>
</article-title>. <source xml:lang="en">Pol J Microbiol</source>. <year>2020</year>;<volume>69</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.33073/pjm-2020-007</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="prp2761-cit-0059">
<string-name>
<surname>Yang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Michel</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Chaumont</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Millet&#x02010;Clerc</surname>
<given-names>J</given-names>
</string-name>. <article-title>Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis</article-title>. <source xml:lang="en">Mycopathologia</source>. <year>1999</year>;<volume>148</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02010;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1023/a:1007178924408</pub-id>
<pub-id pub-id-type="pmid">11189747</pub-id></mixed-citation></ref><ref id="prp2761-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="prp2761-cit-0060">
<string-name>
<surname>Magiatis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Skaltsounis</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Chinou</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Haroutounian</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Chemical composition and in&#x02010;vitro antimicrobial activity of the essential oils of three Greek Achillea species</article-title>. <source xml:lang="en">Z Naturforsch C J Biosci</source>. <year>2002</year>;<volume>57</volume>(<issue>3&#x02010;4</issue>):<fpage>287</fpage>&#x02010;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2002-3-415</pub-id>
<pub-id pub-id-type="pmid">12064728</pub-id></mixed-citation></ref><ref id="prp2761-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="prp2761-cit-0061">
<string-name>
<surname>Bougatsos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ngassapa</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Runyoro</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Chinou</surname>
<given-names>IB</given-names>
</string-name>. <article-title>Chemical composition and in vitro antimicrobial activity of the essential oils of two Helichrysum species from Tanzania</article-title>. <source xml:lang="en">Z Naturforsch C J Biosci</source>. <year>2004</year>;<volume>59</volume>(<issue>5&#x02010;6</issue>):<fpage>368</fpage>&#x02010;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2004-5-614</pub-id>
<pub-id pub-id-type="pmid">18998403</pub-id></mixed-citation></ref><ref id="prp2761-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="prp2761-cit-0062">
<string-name>
<surname>Inoue</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Shiraishi</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hada</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hamashima</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shimada</surname>
<given-names>J</given-names>
</string-name>. <article-title>The antibacterial effects of myrcene on <italic>Staphylococcus aureus</italic> and its role in the essential oil of the tea tree (<italic>Melaleuca alternifolia</italic>)</article-title>. <source xml:lang="en">Nat Med</source>. <year>2004</year>;<volume>58</volume>:<fpage>10</fpage>&#x02010;<lpage>14</lpage>.</mixed-citation></ref><ref id="prp2761-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="prp2761-cit-0063">
<string-name>
<surname>Subramenium</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Vijayakumar</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pandian</surname>
<given-names>SK</given-names>
</string-name>. <article-title>Limonene inhibits streptococcal biofilm formation by targeting surface&#x02010;associated virulence factors</article-title>. <source xml:lang="en">J Med Microbiol</source>. <year>2015</year>;<volume>64</volume>(<issue>8</issue>):<fpage>879</fpage>&#x02010;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.000105</pub-id>
<pub-id pub-id-type="pmid">26294065</pub-id></mixed-citation></ref><ref id="prp2761-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="prp2761-cit-0064">
<string-name>
<surname>Han</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>W</given-names>
</string-name>. <article-title>Antimicrobial susceptibility and antibacterial mechanism of limonene against <italic>Listeria monocytogenes</italic>
</article-title>. <source xml:lang="en">Molecules</source>. <year>2019</year>;<volume>25</volume>(<issue>1</issue>):<fpage>33</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25010033</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="prp2761-cit-0065">
<string-name>
<surname>da Silva Rivas</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Lopes</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>de Azevedo Barros</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Costa Machado</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Alviano</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Alviano</surname>
<given-names>DS</given-names>
</string-name>. <article-title>Biological activities of &#x003b1;&#x02010;pinene and &#x003b2;&#x02010;pinene enantiomers</article-title>. <source xml:lang="en">Molecules</source>. <year>2012</year>;<volume>17</volume>(<issue>6</issue>):<fpage>6305</fpage>&#x02010;<lpage>6316</lpage>. <pub-id pub-id-type="doi">10.3390/molecules17066305</pub-id>
<pub-id pub-id-type="pmid">22634841</pub-id></mixed-citation></ref><ref id="prp2761-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="prp2761-cit-0066">
<string-name>
<surname>Zengin</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Menghini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Di Sotto</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Chromatographic analyses, in vitro biological activities, and cytotoxicity of <italic>Cannabis sativa</italic> L. essential oil: a multidisciplinary study</article-title>. <source xml:lang="en">Molecules</source>. <year>2018</year>;<volume>23</volume>(<issue>12</issue>):<fpage>3266</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23123266</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="prp2761-cit-0067">
<string-name>
<surname>Marini</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Magi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ferretti</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Attenuation of <italic>Listeria monocytogenes</italic> virulence by <italic>Cannabis sativa</italic> L. essential oil</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>. <year>2018</year>;<volume>8</volume>:<fpage>293</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00293</pub-id>
<pub-id pub-id-type="pmid">30186775</pub-id></mixed-citation></ref><ref id="prp2761-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="prp2761-cit-0068">
<string-name>
<surname>Van Klingeren</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ten Ham</surname>
<given-names>M</given-names>
</string-name>. <article-title>Antibacterial activity of delta9&#x02010;tetrahydrocannabinol and cannabidiol</article-title>. <source xml:lang="en">Antonie Van Leeuwenhoek</source>. <year>1976</year>;<volume>42</volume>(<issue>1&#x02010;2</issue>):<fpage>9</fpage>&#x02010;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/BF00399444</pub-id>
<pub-id pub-id-type="pmid">1085130</pub-id></mixed-citation></ref><ref id="prp2761-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="prp2761-cit-0069">
<string-name>
<surname>Eisohly</surname>
<given-names>HN</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Clark</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Eisohly</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds</article-title>. <source xml:lang="en">J Pharm Sci</source>. <year>1982</year>;<volume>71</volume>(<issue>12</issue>):<fpage>1319</fpage>&#x02010;<lpage>1323</lpage>. <pub-id pub-id-type="doi">10.1002/jps.2600711204</pub-id>
<pub-id pub-id-type="pmid">7153877</pub-id></mixed-citation></ref><ref id="prp2761-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="prp2761-cit-0070">
<string-name>
<surname>Radwan</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Elsohly</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Slade</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Ross</surname>
<given-names>SA</given-names>
</string-name>. <article-title>Biologically active cannabinoids from high&#x02010;potency <italic>Cannabis sativa</italic>
</article-title>. <source xml:lang="en">J Nat Prod</source>. <year>2009</year>;<volume>72</volume>(<issue>5</issue>):<fpage>906</fpage>&#x02010;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1021/np900067k</pub-id>
<pub-id pub-id-type="pmid">19344127</pub-id></mixed-citation></ref><ref id="prp2761-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="prp2761-cit-0071">
<string-name>
<surname>Stahl</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vasudevan</surname>
<given-names>K</given-names>
</string-name>. <article-title>Comparison of efficacy of cannabinoids versus commercial oral care products in reducing bacterial content from dental plaque: a preliminary observation</article-title>. <source xml:lang="en">Cureus</source>. <year>2020</year>;<volume>12</volume>(<issue>1</issue>):<elocation-id>e6809</elocation-id>. <pub-id pub-id-type="doi">10.7759/cureus.6809</pub-id>
<pub-id pub-id-type="pmid">32038896</pub-id></mixed-citation></ref><ref id="prp2761-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="prp2761-cit-0072">
<string-name>
<surname>Appendino</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gibbons</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Giana</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Antibacterial cannabinoids from <italic>Cannabis sativa</italic>: a structure&#x02010;activity study</article-title>. <source xml:lang="en">J Nat Prod</source>. <year>2008</year>;<volume>71</volume>(<issue>8</issue>):<fpage>1427</fpage>&#x02010;<lpage>1430</lpage>. <pub-id pub-id-type="doi">10.1021/np8002673</pub-id>
<pub-id pub-id-type="pmid">18681481</pub-id></mixed-citation></ref><ref id="prp2761-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="prp2761-cit-0073">
<string-name>
<surname>Farha</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Halfawy</surname>
<given-names>OM</given-names>
</string-name>, <string-name>
<surname>Gale</surname>
<given-names>RT</given-names>
</string-name>, et al. <article-title>Uncovering the hidden antibiotic potential of Cannabis</article-title>. <source xml:lang="en">ACS Infect Dis</source>. <year>2020</year>;<volume>6</volume>(<issue>3</issue>):<fpage>338</fpage>&#x02010;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00419</pub-id>
<pub-id pub-id-type="pmid">32017534</pub-id></mixed-citation></ref><ref id="prp2761-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="prp2761-cit-0074">
<string-name>
<surname>Feldman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Smoum</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mechoulam</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Steinberg</surname>
<given-names>D</given-names>
</string-name>. <article-title>Potential combinations of endocannabinoid/endocannabinoid&#x02010;like compounds and antibiotics against methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic>
</article-title>. <source xml:lang="en">PLoS One</source>. <year>2020</year>;<volume>15</volume>(<issue>4</issue>):<elocation-id>e0231583</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0231583</pub-id>
<pub-id pub-id-type="pmid">32294120</pub-id></mixed-citation></ref><ref id="prp2761-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="prp2761-cit-0075">
<string-name>
<surname>Martinenghi</surname>
<given-names>LD</given-names>
</string-name>, <string-name>
<surname>J&#x000f8;nsson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lund</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Jenssen</surname>
<given-names>H</given-names>
</string-name>. <article-title>Isolation, purification, and antimicrobial characterization of cannabidiolic acid and cannabidiol from <italic>Cannabis sativa</italic> L</article-title>. <source xml:lang="en">Biomolecules</source>. <year>2020</year>;<volume>10</volume>(<issue>6</issue>):<fpage>900</fpage>. <pub-id pub-id-type="doi">10.3390/biom10060900</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="prp2761-cit-0076">
<string-name>
<surname>Galletta</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Reekie</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Nagalingam</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Rapid antibacterial activity of cannabichromenic acid against methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic>
</article-title>. <source xml:lang="en">Antibiotics (Basel)</source>. <year>2020</year>;<volume>9</volume>(<issue>8</issue>):<fpage>523</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics9080523</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="prp2761-cit-0077">
<string-name>
<surname>Kosgodage</surname>
<given-names>US</given-names>
</string-name>, <string-name>
<surname>Matewele</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Awamaria</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Cannabidiol is a novel modulator of bacterial membrane vesicles</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>. <year>2019</year>;<volume>9</volume>:<fpage>324</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2019.00324</pub-id>
<pub-id pub-id-type="pmid">31552202</pub-id></mixed-citation></ref><ref id="prp2761-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="prp2761-cit-0078">
<string-name>
<surname>Wassmann</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>H&#x000f8;jrup</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Klitgaard</surname>
<given-names>JK</given-names>
</string-name>. <article-title>Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram&#x02010;positive bacteria</article-title>. <source xml:lang="en">Sci. Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>4112</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-60952-0</pub-id>
<pub-id pub-id-type="pmid">32139776</pub-id></mixed-citation></ref><ref id="prp2761-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="prp2761-cit-0079">
<string-name>
<surname>Feldman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sionov</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>SmoumR</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Ginsburg</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Steinberg</surname>
<given-names>D</given-names>
</string-name>. <article-title>Comparative evaluation of combinatory interaction between endocannabinoid system compounds and poly&#x02010;L&#x02010;lysine against <italic>Streptococcus mutans</italic> growth and biofilm formation</article-title>. <source xml:lang="en">Biomed Res Int</source>. <year>2020</year>;<volume>2020</volume>:<fpage>1</fpage>&#x02010;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1155/2020/7258380</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="prp2761-cit-0080">
<string-name>
<surname>Soni</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Smoum</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Breuer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mechoulam</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Steinberg</surname>
<given-names>D</given-names>
</string-name>. <article-title>Effect of the synthetic cannabinoid HU&#x02010;210 on quorum sensing and on the production of quorum sensing&#x02010;mediated virulence factors by <italic>Vibrio harveyi</italic>
</article-title>. <source xml:lang="en">BMC Microbiol</source>. <year>2015</year>;<volume>15</volume>:<fpage>159</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-015-0499-0</pub-id>
<pub-id pub-id-type="pmid">26264142</pub-id></mixed-citation></ref><ref id="prp2761-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="prp2761-cit-0081">
<string-name>
<surname>Sadgrove</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>GL</given-names>
</string-name>. <article-title>From petri dish to patient: bioavailability estimation and mechanism of action for antimicrobial and immunomodulatory natural products</article-title>. <source xml:lang="en">Front Microbiol</source>. <year>2019</year>;<volume>10</volume>:<fpage>2470</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.02470</pub-id>
<pub-id pub-id-type="pmid">31736910</pub-id></mixed-citation></ref><ref id="prp2761-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="prp2761-cit-0082">
<string-name>
<surname>Tanasescu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Constantinescu</surname>
<given-names>CS</given-names>
</string-name>. <article-title>Cannabinoids and the immune system: an ovComparative evaluation of combinatory interaction berview</article-title>. <source xml:lang="en">Immunobiology</source>. <year>2010</year>;<volume>215</volume>(<issue>8</issue>):<fpage>588</fpage>&#x02010;<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2009.12.005</pub-id>
<pub-id pub-id-type="pmid">20153077</pub-id></mixed-citation></ref><ref id="prp2761-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="prp2761-cit-0083">
<string-name>
<surname>Almogi&#x02010;Hazan</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Or</surname>
<given-names>R</given-names>
</string-name>. <article-title>
<italic>Cannabis</italic>, the endocannabinoid system and immunity&#x02010;the journey from the bedside to the bench and back</article-title>. <source xml:lang="en">Int J Mol Sci</source>. <year>2020</year>;<volume>21</volume>(<issue>12</issue>):<fpage>4448</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21124448</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="prp2761-cit-0084">
<string-name>
<surname>Van der Poll</surname>
<given-names>T</given-names>
</string-name>. <article-title>Preclinical sepsis models</article-title>. <source xml:lang="en">Surg Infect</source>. <year>2012</year>;<volume>13</volume>(<issue>5</issue>):<fpage>287</fpage>&#x02010;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1089/sur.2012.105</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="prp2761-cit-0085">
<string-name>
<surname>Duncan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Galic</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation</article-title>. <source xml:lang="en">Am J Physiol Regul Integr Comp Physiol</source>. <year>2013</year>;<volume>305</volume>(<issue>3</issue>):<fpage>R224</fpage>&#x02010;<lpage>R231</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00104.2013</pub-id>
<pub-id pub-id-type="pmid">23739343</pub-id></mixed-citation></ref><ref id="prp2761-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="prp2761-cit-0086">
<string-name>
<surname>Gui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>DF</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>. <article-title>Cannabinoid receptor 2 protects against acute experimental sepsis in mice</article-title>. <source xml:lang="en">Mediators Inflamm</source>. <year>2013</year>;<volume>2013</volume>:<fpage>741303</fpage>. <pub-id pub-id-type="doi">10.1155/2013/741303</pub-id>
<pub-id pub-id-type="pmid">23781122</pub-id></mixed-citation></ref><ref id="prp2761-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="prp2761-cit-0087">
<string-name>
<surname>Ribeiro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ferraz&#x02010;de&#x02010;Paula</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Pinheiro</surname>
<given-names>ML</given-names>
</string-name>, et al. <article-title>Cannabidiol, a non&#x02010;psychotropic plant&#x02010;derived cannabinoid, decreases inflammation in a murine model of acute lung injury: a role for the adenosine A(2A) receptor</article-title>. <source xml:lang="en">Eur J Pharmacol</source>. <year>2012</year>;<volume>678</volume>(<issue>1&#x02010;3</issue>):<fpage>78</fpage>&#x02010;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2011.12.043</pub-id>
<pub-id pub-id-type="pmid">22265864</pub-id></mixed-citation></ref><ref id="prp2761-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="prp2761-cit-0088">
<string-name>
<surname>Ribeiro</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Almeida</surname>
<given-names>VI</given-names>
</string-name>, <string-name>
<surname>Costola&#x02010;de&#x02010;Souza</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Cannabidiol improves lung function and inflammation in mice submitted to LPS&#x02010;induced acute lung injury</article-title>. <source xml:lang="en">Immunopharmacol Immunotoxicol</source>. <year>2015</year>;<volume>37</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02010;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.3109/08923973.2014.976794</pub-id>
<pub-id pub-id-type="pmid">25356537</pub-id></mixed-citation></ref><ref id="prp2761-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="prp2761-cit-0089">
<string-name>
<surname>Karmaus</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Harkema</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Kaminski</surname>
<given-names>NE</given-names>
</string-name>, <string-name>
<surname>Kaplan</surname>
<given-names>BL</given-names>
</string-name>. <article-title>Cannabidiol (CBD) enhances lipopolysaccharide (LPS)&#x02010;induced pulmonary inflammation in C57BL/6 mice</article-title>. <source xml:lang="en">J Immunotoxicol</source>. <year>2013</year>;<volume>10</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02010;<lpage>328</lpage>. <pub-id pub-id-type="doi">10.3109/1547691X.2012.741628</pub-id>
<pub-id pub-id-type="pmid">23173851</pub-id></mixed-citation></ref><ref id="prp2761-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="prp2761-cit-0090">
<string-name>
<surname>Hern&#x000e1;ndez&#x02010;Cervantes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>M&#x000e9;ndez&#x02010;D&#x000ed;az</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Prosp&#x000e9;ro&#x02010;Garc&#x000ed;a</surname>
<given-names>&#x000d3;</given-names>
</string-name>, <string-name>
<surname>Morales&#x02010;Montor</surname>
<given-names>J</given-names>
</string-name>. <article-title>Immunoregulatory role of cannabinoids during infectious disease</article-title>. <source xml:lang="en">NeuroImmunoModulation</source>. <year>2017</year>;<volume>24</volume>(<issue>4&#x02010;5</issue>):<fpage>183</fpage>&#x02010;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1159/000481824</pub-id>
<pub-id pub-id-type="pmid">29151103</pub-id></mixed-citation></ref><ref id="prp2761-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="prp2761-cit-0091">
<string-name>
<surname>Bradley</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Munson</surname>
<given-names>AE</given-names>
</string-name>, <string-name>
<surname>Dewey</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>LS</given-names>
</string-name>. <article-title>Enhanced susceptibility of mice to combinations of delta 9&#x02010;tetrahydrocannabinol and live or killed gram&#x02010;negative bacteria</article-title>. <source xml:lang="en">Infect Immun</source>. <year>1977</year>;<volume>17</volume>(<issue>2</issue>):<fpage>325</fpage>&#x02010;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.17.2.325-329.1977</pub-id>
<pub-id pub-id-type="pmid">330405</pub-id></mixed-citation></ref><ref id="prp2761-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="prp2761-cit-0092">
<string-name>
<surname>Morahan</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Klykken</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Munson</surname>
<given-names>AE</given-names>
</string-name>. <article-title>Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus</article-title>. <source xml:lang="en">Infect Immun</source>. <year>1979</year>;<volume>23</volume>(<issue>3</issue>):<fpage>670</fpage>&#x02010;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.23.3.670-674.1979</pub-id>
<pub-id pub-id-type="pmid">313368</pub-id></mixed-citation></ref><ref id="prp2761-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="prp2761-cit-0093">
<string-name>
<surname>Klein</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Newton</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Nakachi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>
<given-names>H</given-names>
</string-name>. <article-title>Delta 9&#x02010;tetrahydrocannabinol treatment suppresses immunity and early IFN&#x02010;gamma, IL&#x02010;12, and IL&#x02010;12 receptor beta 2 responses to <italic>Legionella pneumophila</italic> infection</article-title>. <source xml:lang="en">J Immunol</source>. <year>2000</year>;<volume>164</volume>(<issue>12</issue>):<fpage>6461</fpage>&#x02010;<lpage>6466</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.164.12.6461</pub-id>
<pub-id pub-id-type="pmid">10843702</pub-id></mixed-citation></ref><ref id="prp2761-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="prp2761-cit-0094">
<string-name>
<surname>Klein</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Cabral</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Cannabinoid&#x02010;induced immune suppression and modulation of antigen&#x02010;presenting cells</article-title>. <source xml:lang="en">J Neuroimmune Pharmacol</source>. <year>2006</year>;<volume>1</volume>(<issue>1</issue>):<fpage>50</fpage>&#x02010;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-005-9007-x</pub-id>
<pub-id pub-id-type="pmid">18040791</pub-id></mixed-citation></ref><ref id="prp2761-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="prp2761-cit-0095">
<string-name>
<surname>Lu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Newton</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Perkins</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>TW</given-names>
</string-name>. <article-title>Role of cannabinoid receptors in Delta&#x02010;9&#x02010;tetrahydrocannabinol suppression of IL&#x02010;12p40 in mouse bone marrow&#x02010;derived dendritic cells infected with <italic>Legionella pneumophila</italic>
</article-title>. <source xml:lang="en">Eur J Pharmacol</source>. <year>2006</year>;<volume>532</volume>(<issue>1&#x02013;2</issue>):<fpage>170</fpage>&#x02010;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2005.12.040</pub-id>
<pub-id pub-id-type="pmid">16443217</pub-id></mixed-citation></ref><ref id="prp2761-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="prp2761-cit-0096">
<string-name>
<surname>Barichello</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ceretta</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Generoso</surname>
<given-names>JS</given-names>
</string-name>, et al. <article-title>Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis</article-title>. <source xml:lang="en">Eur J Pharmacol</source>. <year>2012</year>;<volume>697</volume>(<issue>1&#x02010;3</issue>):<fpage>158</fpage>&#x02010;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2012.09.053</pub-id>
<pub-id pub-id-type="pmid">23085269</pub-id></mixed-citation></ref><ref id="prp2761-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="prp2761-cit-0097">
<string-name>
<surname>Cassol</surname>
<given-names>OJ</given-names>
<suffix>Jr</suffix>
</string-name>, <string-name>
<surname>Comim</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>BR</given-names>
</string-name>, et al. <article-title>Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture</article-title>. <source xml:lang="en">Brain Res</source>. <year>2010</year>;<volume>1348</volume>:<fpage>128</fpage>&#x02010;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.06.023</pub-id>
<pub-id pub-id-type="pmid">20561509</pub-id></mixed-citation></ref><ref id="prp2761-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="prp2761-cit-0098">
<string-name>
<surname>Beaulieu</surname>
<given-names>P</given-names>
</string-name>. <article-title>Toxic effects of cannabis and cannabinoids: animal data</article-title>. <source xml:lang="en">Pain Res Manag</source>. <year>2005</year>;<volume>10</volume>(<issue>suppl A</issue>):<fpage>23A</fpage>&#x02010;<lpage>26A</lpage>. <pub-id pub-id-type="doi">10.1155/2005/763623</pub-id>
</mixed-citation></ref><ref id="prp2761-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="prp2761-cit-0099">
<string-name>
<surname>Thompson</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Rosenkrantz</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Schaeppi</surname>
<given-names>UH</given-names>
</string-name>, <string-name>
<surname>Braude</surname>
<given-names>MC</given-names>
</string-name>. <article-title>Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys</article-title>. <source xml:lang="en">Toxicol Appl Pharmacol</source>. <year>1973</year>;<volume>25</volume>(<issue>3</issue>):<fpage>363</fpage>&#x02010;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/0041-008x(73)90310-4</pub-id>
<pub-id pub-id-type="pmid">4199474</pub-id></mixed-citation></ref><ref id="prp2761-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="prp2761-cit-0100">
<string-name>
<surname>Deiana</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yamasaki</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarin (CBDV), &#x00394;&#x02079;&#x02010;tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive&#x02010;compulsive behavior</article-title>. <source xml:lang="en">Psychopharmacology</source>. <year>2012</year>;<volume>219</volume>(<issue>3</issue>):<fpage>859</fpage>&#x02010;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-011-2415-0</pub-id>
<pub-id pub-id-type="pmid">21796370</pub-id></mixed-citation></ref><ref id="prp2761-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="prp2761-cit-0101">
<string-name>
<surname>Vaughn</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kulpa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Paulionis</surname>
<given-names>L</given-names>
</string-name>. <article-title>Preliminary investigation of the safety of escalating cannabinoid doses in healthy dogs</article-title>. <source xml:lang="en">Front Vet Sci</source>. <year>2020</year>;<volume>7</volume>:<fpage>51</fpage>. <pub-id pub-id-type="doi">10.3389/fvets.2020.00051</pub-id>
<pub-id pub-id-type="pmid">32118071</pub-id></mixed-citation></ref><ref id="prp2761-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="prp2761-cit-0102">
<string-name>
<surname>Zuardi</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Crippa</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Hallak</surname>
<given-names>JE</given-names>
</string-name>, et al. <article-title>A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation</article-title>. <source xml:lang="en">Curr Pharm Des</source>. <year>2012</year>;<volume>18</volume>(<issue>32</issue>):<fpage>5131</fpage>&#x02010;<lpage>5140</lpage>. <pub-id pub-id-type="doi">10.2174/138161212802884681</pub-id>
<pub-id pub-id-type="pmid">22716160</pub-id></mixed-citation></ref><ref id="prp2761-bib-0103"><label>103</label><mixed-citation publication-type="miscellaneous" id="prp2761-cit-0103">
<article-title>WHO Expert Committee on Drug Dependence, fortieth report</article-title>. Geneva: World Health Organization; 2018 (WHO Technical Report Series, No. 1013). License: CC BY&#x02010;NC&#x02010;SA 3.0 IGO. Available online at <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/279948/9789241210225-eng.pdf?ua=1">https://apps.who.int/iris/bitstream/handle/10665/279948/9789241210225&#x02010;eng.pdf?ua=1</ext-link>. Accessed August 10, 2020.</mixed-citation></ref><ref id="prp2761-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="prp2761-cit-0104">
<string-name>
<surname>Harding</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Sharman</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Faccenda</surname>
<given-names>E</given-names>
</string-name>, et al. <article-title>The IUPHAR/BPS Guide to PHARMACOLOGY in 2019: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>:<fpage>D1091</fpage>&#x02010;<lpage>D106</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1121</pub-id>
<pub-id pub-id-type="pmid">29149325</pub-id></mixed-citation></ref><ref id="prp2761-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="prp2761-cit-0105">
<string-name>
<surname>Alexander</surname>
<given-names>SPH</given-names>
</string-name>, <string-name>
<surname>Christopoulos</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Davenport</surname>
<given-names>AP</given-names>
</string-name>, et al. <article-title>THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein&#x02010;coupled receptors</article-title>. <source xml:lang="en">Br J Pharmacol</source>. <year>2019</year>;<volume>176</volume>:<fpage>S21</fpage>&#x02010;<lpage>S141</lpage>. <pub-id pub-id-type="doi">10.1111/bph.14748</pub-id>
<pub-id pub-id-type="pmid">31710717</pub-id></mixed-citation></ref></ref-list></back></article>